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Abstract  
Preeclampsia (PE) is a pregnancy-related disorder affecting 5-8% of women worldwide (4% in 
Norway). It is believed that placental ischemia is the initial event in the development of PE and 
is characterized by placental insufficiency and clinical symptoms such as hypertension and 
proteinuria. In this project, we aimed to study suitable biomarkers for morphological analysis 
of human term placenta from normal pregnancies and women with PE using advanced 
fluorescence microscopes.  
To reach this objective, we optimized the labeling steps for advanced fluorescence optical 
microscopy imaging of formalin-fixed paraffin-embedded (FFPE) and cryo-preserved tissue 
sections of the human placenta. Furthermore, morphological and subcellular differences 
between healthy and preeclamptic placentas were investigated. For this, various fluorescence 
microscopy techniques were explored, including whole-slide scanner, high-resolution 
deconvolution microscopy (DV) and super-resolution structured illumination microscopy 
(SIM), along with diverse image processing tools and analysis of the microscopy images. In 
this thesis, diverse strategies were examined for the labeling of placental biomarkers including 
immunofluorescence staining of laeverin, cytokeratin-7 (CK-7) and placental alkaline 
phosphatase (PLAP), as well as direct labeling of F-actin, membranes and nuclei via phalloidin-
Atto 647 N, CellMask Orange (CMO) and DAPI, respectively.  
The microscopy investigation revealed actin spots abundantly localized in subtypes of the 
chorionic villi in both healthy and PE placentas, such as terminal villi (p-value 0.55), mature 
intermediate villi (p-value 0.50), immature intermediate villi (p-value 0.54) and stem villi (p-
value 0.47), thus no observable differences. However, we found significant differences (p-value 
0.015) of syncytial knots in PE compared to healthy tissue. A disorganized brushborder at the 
apical surface seems to be observed in the PE chorionic villi. Moreover, we found PLAP 
expression in the syncytial microvesicles in healthy placentas. The immunofluorescence study 
using laeverin and CK-7 antibodies seem to show co-localization in the syncytial plasma 
membrane in healthy placentas, though the labeled PE tissues showed laeverin expression in 
the syncytial plasma membrane and cytoplasm, including overexpression of laeverin in the fetal 
capillaries.  
In conclusion, the biomarkers explored in this study may have the potential to play an important 
role in understanding and predict PE in the future.  
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The placenta is a highly specialized organ only present during pregnancy. The organ is vital for 
the normal growth and development of the fetus and maternal health (1). When the placenta 
fails to develop normally, several complications such as preeclampsia (PE) may rise. 
Preeclampsia is a pregnancy-specific disorder affecting 5-8% of women during pregnancy 
worldwide (4% in Norway) (2, 3). The only cure for the disorder is to fully remove the organ. 
The etiology of preeclampsia is still unknown. However, it is believed that placenta ischemia 
produces soluble toxic factors that are released into the maternal circulation causing placental 
dysfunction. Because placenta ischemia might be the root cause of PE, it is necessary to 
investigate the differences between normal healthy placentas and preeclamptic placentas, thus 
various placental-specific biomarkers are used to investigate morphological changes in the 
placenta (4, 5). For this reason, placental biomarker studies may potentially play a key role in 
understanding the disorder and for prediction at an early stage.  
The morphology studies of placental pathology are one of the cornerstones of diagnosis of 
abnormal pregnancies and one of the research focuses of the Women’s Health and Perinatology 
Research Group at the Department of Clinical Medicine at The Arctic University of Norway 
(UiT). Their main emphasis is on translational and clinical research in women’s health and 
perinatology which includes fetal-maternal physiology and genetics, placenta, reproductive 
biology and immunology, evidence-based pregnancy care and epidemiology, urogynaecology 
and chronic pelvic pain (6). 
The Master thesis was performed at the Women’s Health and Perinatology Research Group, 
Department of Clinical Medicine (UiT) in collaboration with the Optical Nanoscopy Research 
Group, Department of Physics and Technology (UiT). The aim of the collaboration was to shed 
light on the pathophysiological mechanisms of preeclampsia with the use of advanced 
fluorescence microscopy methods.  
Due to the interest in this field in addition to limited studies associated with advanced optical 
fluorescence microscopy methods, this master project was created. Thus, the primary aims for 
the master project were to optimize the sample preparation-steps of formalin-fixed paraffin-
embedded and cryo-preserved human placental tissue sections for fluorescence high-resolution 
and super-resolution imaging using advanced microscopy methods. These included a whole-
slide scanner (Olympus VS120), high-resolution deconvolution microscope (DV) and super-
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resolution structured illumination microscope (SIM). The secondary aim of the thesis was to 
investigate relevant and suitable fluorescence placental biomarkers for ultrastructural and 
subcellular investigation of placentas. Additionally, we wanted to compare placentas from 
women that have had preeclampsia with placentas from women with healthy pregnancies and 
to identify morphological changes between them.  
Furthermore, the findings from the study using different placental-specific biomarkers and 
direct fluorescent dyes might contribute to a better understanding of the preeclampsia. 
Additionally, our ultimate goal for future research is to develop a type of pregnancy test, which 
can be taken early in pregnancy to detect and monitor women at risk of developing preeclampsia 
to mitigate potential threats to women and their fetuses. This study was the first step in the 
direction to reach that goal; the goal of developing a prediction assay for PE.   
The preliminary study for immunofluorescence investigation started with optimization of the 
methods for FFPE- and cryo-sections of human full-term placenta tissues from healthy and 
preeclamptic pregnancies. The optimization stage – 75% research time (Figure 1) included 
optimizing the sample preparation, concentration and incubation times for biomarkers and 
direct fluorescent dyes and investigating different labeling techniques suitable for FFPE- and 
cryo-sections for the advanced optical imaging method. Both, DV and OMX microscopes were 
used for the optimization stage. After acquiring the optimal methodology, the morphology 
investigation began – 25% research time. The morphology study included investigating 
structural and subcellular differences of the immunofluorescence labeled and direct fluorescent-
labeled healthy and PE placentas using various microscopes (Olympus VS120, DV, OMX).  
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Figure 1 The master project setup. Flowchart represents an overview of the project setup for the experimental 
plan. Stage 1 was the optimization of the methods used for the study, and stage 2 was the morphology study in the 
thesis. 
 
The Master thesis starts with the theoretical framework, followed the methodology used in this 
study. The third and fourth sections consist of experimental results and discussion, respectively. 
The final sections include the conclusion and the future perspectives for the project.  
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1 Theoretical background  
The following section outlines the theoretical background of this study. All the information is 
given to recapitulate the current state of knowledge.  
1.1 Human placenta  
The human placenta is a highly specialized organ present only during pregnancy and plays a 
central role in the health of the mother and the fetus. The organ is essential for normal fetal 
growth and development, ensuring nutrition and oxygen exchange in addition to transporting 
carbon dioxide and metabolic waste away from the fetus (1). Placental pathology may lead to 
abnormal fetal development.  
1.1.1 Early placental development  
Embryonic development, also known as embryogenesis, begins with fertilization which 
initiates the pregnancy. Human fertilization occurs when a male haploid gamete (sperm cell) 
fuses with the female haploid gamete (ovum) forming a diploid zygote (7, 8). The fusion of two 
gametes activates the zygote to frequently divide while migrating down the Fallopian tube 
(Figure 2) (9). During 3-4 days after fertilization, a transition from 4- or 8-cell to a compacted 
morula occurs. On day 5, the morula matures into an early blastocyst, consisting of cells 
forming an outer layer of human trophectoderm (hTED), a fluid-filled cavity and an inner cell 
mass (ICM). The human trophectoderm gives rise to human trophoblast cells (hTB). The ICM 
is the origin of the human embryo and human umbilical cord (hUC) including placental 
mesenchyme (1, 10). Day 6-7, the blastocyst hatches leaving the protective zona pellucida and 
thus allowing trophoblast migration and invasion into the maternal uterine epithelium wall 
which initiates the formation of the human placenta (10). The formation of the placenta starts 
when hTB differentiates into the human syncytiotrophoblast (hSTB) invading the myometrium. 
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Figure 2 Fertilization of a human egg in the Fallopian tube and implantation of a blastocyst. Fertilization of 
the egg with a sperm cell occurs on Day 0. The fertilized egg proliferates and divides while migrating through the 
Fallopian tube in the uterus (Day 1-4). On day 5, the preimplantation stage begins, where the morula gives rise 
to an early blastocyst consisting of human trophectoderm (hTED), blastocoel (blastocyst cavity) and inner cell 
mass (ICM). On day 6-7 the blastocyst hatches and day 8-9, the blastocyst implants in the uterine wall (maternal 
decidua). Formation of the human placenta has begun when the human trophoblast cells (hTB) differentiate into 
human syncytiotrophoblast invading the myometrium. From: Winslow, T., 2001 (11).  
 
1.1.2 Trophoblasts – the major constituents of the placenta  
The structure of the human placenta is complex. The uterine wall (epithelial wall) is located in 
the uterus and transforms into human decidua (hD) (Figure 3A) (10). The human trophoblast 
cells (hTB) undergo extensive proliferation and differentiates into various types of cells 
forming the human chorionic villi (hCV) (1). The human cytotrophoblasts (hCTB) are stem 
cells forming the inner layer of the human chorionic villi (hCV) with the basement membrane 
(Figure 3B). Further, the hCTB cells divide and differentiate into multinucleated 
syncytiotrophoblast (hSTB), also called syncytium, localized at the outer layer of hCV (10). 
The hSTB are in direct contact with the maternal blood and are the site of maternal-fetal gas 
and nutrients exchange. The remaining hCTB that are in contact with the hD, which 
differentiates into human extravillous trophoblast cells (hEVT) (10). The hEVT migrates into 
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the hD and initiates uterine artery remodeling and enables maternal blood to flow into the 
intervillous space of the placenta (1, 12, 13). The hEVT anchor the placenta. The villous tree is 
furthermore developed by the remaining hSTB located in between the lacunae which are called 
trabeculae (13, 14).  
 
 
Figure 3 Structure of human term placenta.  (A) Structure of a placenta and fetus in a human uterus. The fetus 
is connected to the placenta through the umbilical cord. The uterine epithelial wall transforms into human decidua 
(hD). Human trophoblast cells (hTB) proliferate and differentiate into forming human chorionic villi (hCV) which 
are in direct contact with the maternal blood. (B) Enlargement of boxed region from (A). An overview of the villous 
tree in the placenta which is covered by a basement membrane (purple) and human cytotrophoblast cells (hCTB) 
that are overlined by the human syncytiotrophoblast (hSTB/syncytium). HSTB forms a barrier between the fetus 
and the mother where gas and nutrients exchange. The fetal blood vessels (fetal capillaries) are located inside the 
villous. Some cytotrophoblast cells differentiate into human extravillous trophoblast cells (hEVT) which are in 
direct contact with the hD and anchor the placenta in the uterus. The figure is retrieved and modified from: 




1.1.3 From trophoblast differentiation to fully developed human placenta 
at term 
A fully developed human placenta at term is 500-600 gram, 2-3 centimeter thick and 15-20 
centimeter in diameter (15, 16). The human placenta is composed of both maternal tissues 
derived from the endometrium and the fetal tissues derived from hTB (1). The fetal region of 
the human placenta, called the human chorionic plate (hCP), consists of fetal blood vessels 
branching from the human umbilical cord arteries (hUCA) and the human umbilical cord veins 
(hUCV) (Figure 4) (1). The human basal plate (hBP) is located at the maternal part of the 
placenta. This region consists of the maternal spiral artery, maternal vein and human decidua 
(hD). Numerous branched human chorionic villi (hCV) are submerged in maternal blood (1, 
12). 
 
Figure 4 Normal human placenta at term. (A-B) Macroscopic image of a healthy placenta delivered from a 
pregnant woman at term. (A) Fetal side of the placenta showing human umbilical cord (hUC) at the human 
chorionic plate (hCP). (B) The maternal side of the placenta showing human decidua (hD) partly removed. (C) 
Schematic illustration of normal placenta showing the human chorionic plate (hCP) located at the fetal side of the 
human placenta, where the fetal blood vessels branching from the human umbilical cord arteries (hUCA) and 
human umbilical cord vein (hUCV), located within the human umbilical cord (hUC). The intervillous space is 
filled with maternal blood and the human chorionic villi (hCV) that are submerged in the maternal blood. The 
human basal plate (hBP) and human decidua (hD) are located at the maternal region of the placenta. Schematic 
image made with BioRender.com. Macroscopic photos (17), Photo: Bjørn-Kåre Iversen, UiT-The Arctic 
University of Tromsø, Norway. 
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1.1.4 Chorionic villi - microscope identification of subtypes 
The human chorionic villi are a complex structure categorized into different subtypes (Figure 
5A). The hCV are composed of mesenchymal villi (MSV) which are present during the early 
stages of pregnancy and gradually transformed into immature intermediate villi (IIV) (18). 
Mature intermediate villi (MIV) are longer and lack fetal vessels in the stroma compared to the 
immature intermediated villi (18, 19). MIV develops furthermore into terminal villi (TV) that 
are connected to the stem villi (SV) by intermediate structures (18). Large amounts of TV are 
commonly visualized in term placentas. However, it can be difficult to differentiate the different 
subtypes of villi in a histological investigation due to different shapes, sizes and structures. One 
of the factors that may affect the observation is the sectioning angle of the tissue sample, 
resulting in a microscope observation of different forms of the same subtype of the villi (Figure 
5B). 
 
Figure 5 Schematic representation of placental chorionic villi.  (A) The chorionic villi (yellow) in the middle 
show where the different subtypes of villi are located. The arrows display the different subtypes of chorionic villi. 
The chorionic villi are a complex structure in different subtypes: stem villi (SV), terminal villi (TV), mesenchymal 
villous (MSV), immature intermediate villi (IIV) and mature intermediate villi (MIV). The figure is retrieved from 
Baergen RN., 2010 (20). (B) Tissue sectioning at different angles results in observing different shapes, sizes, and 
structures of chorionic villi with the microscope. The black line indicates where the section is made and the 
representative images are shown at the right. The figure is retrieved and modified from: Kingdom, J., 2000 (21). 
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1.1.5 The role of chorionic villi placental function  
The human placenta plays a key role in feto-maternal transport, metabolism, protection against 
foreign and dangerous pathogens and endocrine secretion (1, 22). Terminal villi exchange 
nutrients and gases over the syncytial trophoblast membrane (23, 24). It transports oxygen, 
water, carbohydrate, amino acids, lipid, vitamins, minerals and other essential nutrients to the 
fetus (1, 16). Removal of carbon dioxide, water, urea and other waste products from the fetus 
to the mother occurs over the syncytial plasma membrane to the maternal blood (23). The 
placenta maintains the protection of the fetus from certain xenobiotic molecules, infections, and 
maternal diseases (1). Additionally, the placenta releases hormones that circulate in the 
maternal blood and affect the pregnancy, metabolism, fetus growth, parturition and other 
functions (1, 16, 25). 
 
1.2 Abnormal pregnancy and pregnancy-related disorders  
Health problems may occur during pregnancy affecting either the mother, the fetus or both. The 
most common pregnancy-related disorders that occur before, during or after pregnancy include 
preeclampsia (PE), intrauterine growth restriction (IUGR), preterm labor (PTL) and gestational 
diabetes mellitus (GDM) (26-28). 
1.2.1 Preeclampsia  
Preeclampsia (PE) is a pregnancy-related hypertensive disorder affecting 5-8% of women 
worldwide (2, 4). The disease generally occurs in women during their pregnancy after 20 weeks 
of gestation and frequently near term (29). Diagnosis of preeclampsia is based on hypertension 
(defined as BP ≥140 mmHg systolic and/or BP ≥90 mmHg diastolic) and proteinuria after 20 
weeks of gestation (4). In absence of proteinuria, preeclampsia is defined as the onset of 
hypertension with thrombocytopenia, renal insufficiency, impaired liver function, pulmonary 
edema and cerebral or visual symptoms evidence of systemic disease (4). 
Preeclampsia may be classified into two groups: early preeclampsia (<34 weeks) with a higher 
risk of maternal and fetal complication and late preeclampsia (≥34 weeks) (4). Early-onset 
preeclampsia is characterized as a fetal disorder referred to as a reduction in placental volume, 
intrauterine growth restriction, abnormal uterine and umbilical artery Doppler, low birth 
weight, multi-organ dysfunction, perinatal death and adverse maternal and neonatal outcomes 
(29). Late-onset preeclampsia is often related to the maternal condition with a characterization 
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of a normal placenta, large placental volume, normal fetal growth, normal uterine and umbilical 
artery Doppler and normal birth weight (30). However, early-onset is more severe in 
comparison to late-onset preeclampsia. 
1.2.2 Pathophysiology of preeclampsia 
The root cause of preeclampsia is unknown. However, the disorder results from ischemia of the 
placenta which initiates releases of various soluble factors (earlier called toxins) into the 
maternal circulation that interrupts the pregnancy immunomodulation and thus induces the 
clinical manifestation of the disease (5, 31). Various agents such as genetic factors, abnormal 
trophoblasts, oxidative stress and increased anti-angiotensin II receptor type 1 (AT1) 
autoantibodies may contribute to reduced migration and invasion of the spiral arteries resulting 
in placental dysfunction (Figure 6) (4). Thus, the condition of preeclampsia occurs when 
adaptive responses release inflammatory cytokines, AT1 antibodies, angiogenesis, 
antiangiogenic factors and syncytiotrophoblast-derived particles into the circulatory system of 
the mother (4, 32). All these different factors induce the activation of leukocytes, intravascular 
inflammation, endothelial cell dysfunction and excessive thrombosis. The stimulation of this 




Figure 6 Pathophysiology of preeclampsia.  Different factors including genetic factors, abnormal 
trophoblast/decidual interaction, oxidative stress, and increased AT1 autoantibodies increases the failure of 
physiological transformation of the myometrial segment of the spiral arteries (deep placentation) which leads to 
placental dysfunction. The effect of these factors results in preeclampsia which occurs when adaptive responses 
release inflammatory cytokines, anti-AT1 antibodies, angiogenesis, antiangiogenic factors, and 
syncytiotrophoblast-derived micro-and nanoparticles into the maternal circulatory system. Further, these factors 
initiate leukocytes, intravascular inflammation, endothelial cell dysfunction, and excessive thrombosis may be the 
cause of the multiorgan pathogenicity of preeclampsia. From: Chaiworapongsa et al., 2014 (4).  
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1.2.3 Treatment of Preeclampsia  
To date, there is no specific treatment for preeclampsia. Thus, the only cure is to remove the 
placenta to manage the symptoms (33). Numerous interventions have been tested for the 
prevention of preeclampsia, including low-salt diets, diuretics, fish oil, calcium supplement, 
antioxidants, aspirin and heparin (4, 33, 34). To date, aspirin is the only substance that has been 
shown to have a prophylactic effect for the prevention of PE (33). 
1.2.4 Eclampsia – extreme complication of the preeclampsia  
Eclampsia is an extreme complication of preeclampsia that causes damage to maternal arteries 
and other blood vessels which might restrict the blood flow, leading to swelling in blood vessels 
in the brain, resulting in seizures and maternal death (35-37). The complications followed by 
eclampsia include stroke, hemolysis, elevated liver enzymes, and low platelets (HELLP) 
syndrome, and disseminated intravascular coagulation (38). 
 
1.3 Biomarkers  
The World Health Organization (WHO) defines biomarkers as “any substance, structure, or 
process that can be measured in the body or its product and influence or predict the incidence of 
outcome or disease” (39, 40). Biomarkers, also known as biological markers, are key tools in 
clinical and biomedical research. These types of indicators provide vital information about 
biological mechanisms, pathogenic processes, pharmacologic processes, or therapeutic 
intervention depending on the type of application used for the research purpose.  
1.3.1 Placental biomarkers  
There are several types of biomarkers used to investigate the biological and clinical mechanisms 
of placental and fetal development, including protein-based biomarkers, DNA-based 
biomarkers, RNA-based biomarkers, or biomarkers for predicting fetal outcomes (41). 
Placental biomarkers are used to understand the placental function linking to placental 
physiology, maternal-fetal physiology, including placental abnormality (42). Various 
angiogenic and anti-angiogenic biomarkers are used to investigate PE, where a study led to the 
discovery of over-expression of soluble fms-like tyrosine kinase receptor-1 (sFlt-1) and 
decreased levels of placental growth factor (PIGF) circulating in PE patients (43). Today, the 
sFlt-1/PIGF ratio is used as a predictor for early PE (44). For this study, different chorionic 
villi-specific biomarkers were used such as laeverin (aminopeptidase-Q), cytokeratin-7 (CK-
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7), and placental alkaline phosphatase (PLAP). These biomarkers were chosen for this study 
due to their specificity of expression in the placental cells within the chorionic villi.  
1.3.1.1 Laeverin  
Laeverin is an aminopeptidase-Q specific to the placenta expressed in the plasma membrane of 
human trophoblasts and was first identified by Fujiwara et al., in 2004 (45). The protein is 
expressed on the cell surface of the human embryo-derived extravillous trophoblasts (45, 46). 
According to a study by Nystad et al., the laeverin was expressed in syncytiotrophoblast, 
including cytotrophoblasts cells and extravillous trophoblast cells in the human placenta (47). 
The expression of laeverin protein in the preeclamptic placenta was shown to be significantly 
higher and might be expressed in cytoplasm and microvesicles in cytotrophoblast compared to 
normal placentas (47, 48).  
1.3.1.2 Cytokeratin-7 
Cytokeratin-7 (CK-7) is a low molecular weight cytoskeletal intermediate filament protein of 
cytokeratins. Studies have shown that the expression of the CK-7 is expressed in the cytoplasm 
of the human trophoblast (49, 50). Thus, the CK-7 is commonly used as a cytoplasmic marker 
for identifying the human placental trophoblast cells (47, 50). 
1.3.1.3 Placental Alkaline Phosphatase  
Placental alkaline phosphatase (PLAP) is a syncytiotrophoblast marker used in immunoassays 
and has been proved that PLAP is a particularly useful marker for detecting syncytiotrophoblast 
extracellular vesicles (STBEV) (microvesicles) derived from syncytiotrophoblast (51). Several 
studies have shown an increase in the number of circulating STBEV in early-onset PE 
compared to a normal pregnancy (52, 53).  
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1.4 Mechanism of fluorescence  
Fluorescence microscopy requires that the objects of interest have fluorescence capacity. 
Fluorescence is a spontaneous emission of light that occurs within nanoseconds after the 
absorption of light that is typical of a shorter wavelength. The difference between the excitation 
and emission wavelengths, known as the Stokes shifts, is the critical property that makes 
fluorescence a powerful tool for microscopy (54-56). Fluorophore molecules absorb energy at 
a specific wavelength and re-emit at a different wavelength. Within the fluorophore molecules, 
some electrons will absorb the photon energy and transition from the ground state to an excited 
state (57). When transitioning back to the ground state, the electrons will emit photons at higher 
wavelengths and, consequently, lower energy (58). By using the appropriate filter set, it is 
possible to completely filter out the excitation light and collect the emitted fluorescence, 
allowing the visualization of the fluorescent signal. This approach provides superior contrast to 
conventional labeling techniques in which objects are stained with agents that absorb light, such 
as hematoxylin and eosin (HE) staining, where the amount of light absorbed becomes only 
infinitesimally different from the background (54). 
1.4.1 Direct fluorescent dyes 
Direct fluorescent dyes are reactive dyes (i.e., not raised in animals) conjugated to fluorophores. 
The direct fluorescent dyes are widely used for targeting specific proteins, compartments, 
molecules and structures within a tissue of interest (59). They allow the detection of structures 
of interest on a fluorescence microscope without performing histochemical or 
immunohistochemical methods (60). For this study, the Phalloidin-Atto 647 N marker was used 
to target F-actin and CellMask Orange was used for membrane staining. Additionally, DAPI is 
a common marker for deoxyribonucleic acid (DNA) staining and was used for detecting 
placental nuclei.  
1.4.2 Immunofluorescence technique  
Immunofluorescence microscopy is a powerful technique extensively used in biomedical 
research labs worldwide to analyze and visualize molecules (antigens) of interest. This 
technique provides both high contrast and high specificity of the labeled structures, enabling 
the study of biological mechanisms in both healthy and diseased models (61-63). The principle 
of this technique is to use fluorescently-conjugated antibodies that recognize and detect 
antigens of interest by a fluorescence microscope (64). In this study, immunofluorescence 
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labeling was used as a tool to investigate the occurrence of different biomarkers targeting 
molecular structures within the placenta tissue, such as the laeverin, CK-7 and PLAP.  
1.4.2.1 Antibody and antigen 
An antibody (Ab) is a protein compartment produced as a defense mechanism within the host 
in response to the exposure of a foreign substance called an antigen (65). An antigen is a 
substance that activates the immune system to produce antibodies against it (65). An antigen 
consists of molecules such as proteins, polypeptides, polysaccharides, lipids, or nucleic acids. 
The structure of an antibody is classically Y-shaped and consists of two heavy chains and two 
light chains within a binding site on the short arms (66). The binding site of the antibody is 
highly specific to a particular combination of molecular conformation and component 
molecular groups such as a specific region in an amino acid sequence. The antibody binds to 
the epitope (specific region) located on the surface of the antigen. Antibodies can be either 
monoclonal or polyclonal. Monoclonal antibodies recognize only one epitope, whereas, 
polyclonal antibodies are formed by repeated immunization of the animal that binds to the 
antigen of interest (67).  
1.4.2.2 The direct and indirect technique  
Direct immunofluorescent labeling uses only a single antibody conjugated to a fluorophore 
which binds directly to the antigen (68). Whereas the indirect immunofluorescent assay uses 
unconjugated primary antibodies binding to fluorophore-conjugated secondary antibodies to 
detect the antigen of interest. In the latter method, it is also important that primary and 
secondary antibodies are originated from different species, to avoid cross-reactivity in the 
sample of the secondary antibodies with endogenous immunoglobulin G (IgG) (69). Figure 7 
illustrates the mechanism behind the production of primary and secondary antibodies. First, an 
antigen is inoculated into a rabbit, which produces primary antibodies that are raised against 
that specific antigen, thus enabling the specific binding to the epitope of the antigen. Second, 
an inoculated donkey with rabbit IgG will produce a secondary antibody that will enable the 
binding to the primary antibody raised against the specific rabbit IgG (66).  
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Figure 7 Direct and indirect labeling technique used in immunofluorescence assay. The top panel illustrates 
the mechanism behind the production of primary and secondary antibodies. An antigen is inoculated into a rabbit 
who then produces primary antibodies against that antigen. An inoculated donkey with rabbit IgG produces 
secondary antibodies against that rabbit IgG, enabling the binding to the primary antibodies. The bottom panel 
shows the working principle of both direct and indirect immunofluorescent labeling. In the direct labeling method, 
a fluorescently-tagged primary antibody binds directly to a specific antigen, whereas the indirect labeling 
technique uses two antibodies: a primary antibody bound to a fluorescently-tagged secondary antibody. Schematic 
image made with BioRender.com. 
 
1.4.3 Autofluorescence background 
Generally, successful observation of fluorescence dyes in formalin-fixed paraffin-embedded 
(FFPE) tissue sections is significantly hampered due to natural autofluorescence occurring in 
the tissue. This prevents clear visualization of the labeled tissue section. Autofluorescence 
appears when a biological structure emits fluorescence at a natural level without being 
manipulated by fluorescent dyes (70). Studies have shown that the cause of autofluorescence 
might be due to the presence of native cell components such as red blood cells, collagen, elastin, 
flavins, porphyrins, chlorophyll, lipofuscin, including cyclic ring compounds (NADPH and 
riboflavin), aromatic acids, and cellular organelles (mitochondria and lysosomes) (71-77). 
Additionally, autofluorescence may also occur from fixatives such as neutral buffered formalin, 
a commonly used fixative in tissue preservation that forms covalent bonds between amino 
groups (78). Consequently, fluorescent products are formed resulting in an intense fluorescent 
background (79). Most of the induced autofluorescence in tissue has an emission between 
450   and 650   which overlaps the emission wavelength of fluorophores. Thus, 
autofluorescence might affect the interpretation of the fluorescence signal coming from the 
samples. 
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1.5 Advanced fluorescence optical microscopy  
1.5.1 Deconvolution microscopy  
Deconvolution microscopy (DV) is a diffraction-limited computational technique permitting a 
stack of images to be processed by inexpensive computers in a short time depending on the 
acquisition size and the deconvolution algorithm (56, 80). This technique aims to remove the 
optical blur and reduce statistical noise by using information about the images from the 
microscope to estimate the original object. The cause of blurring and noise in the microscope 
is largely due to the limited aperture of the microscope objective lens. The out-of-focus blur 
and photon noise that degrades the image of the object is removed by the optical sectioning (56, 
81). By moving the focal plane of the objective along the optical axis, it is possible to determine 
the point spread function (PSF) of the microscope (56). If the PSF is known, then deconvolution 
can be performed to remove the blur from the acquired data, thus improving the contrast and 
resolution of the microscope image. DV images are susceptible to reconstruction artifacts 
derived from non-symmetric PSF. Therefore, careful oil matching is required before the 
acquisition of the raw image stack. 
1.5.2 Structured illumination microscopy  
Structured illumination microscopy (SIM) is a super-resolution technique using laser-based 
widefield configuration (82). SIM permits for observation of fluorescence-labeled samples at a 
lateral and axial resolution below the diffraction limit, reaching at most 100  and 300 , 
respectively (83). In SIM, diffracted laser beams at zero-order and/or first order are used to 
illuminate the sample. After passing the microscope objective, the beams interfere at the sample 
plane with each other creating a high spatial frequency stripe-like pattern (82). The overlapping 
between the stripe illumination and the high spatial frequency of the sample creates low spatial 
frequency patterns called Moire fringes that are now within the resolution capabilities of the 
objective lens (82, 84). The information of the small structures in the sample can be 
computationally retrieved from the Moiré fringes. To capture isotropic information in all 
regions and spatial directions, the illumination pattern needs to be shifted in five lateral phase 
steps and rotated in three angles for every focal plane (82). A stack size of at least eight planes 
is required to reconstruct an optical section with super-resolution in all three axes (x, y, z). Due 
to sensitivity to out-of-focus light, artifacts might be generated by imaging with SIM (84). 
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1.5.3 Limitations of fluorescence microscopy  
Despite the advantages of the microscopy methods mentioned above compared to commercial 
brightfield microscopy, fluorescence microscopy has some disadvantages. Photobleaching is 
one of the limitations that might occur using all kinds of fluorescence microscopes. 
Photobleaching is the permanent loss of fluorescence of the dyes due to an irreversible chemical 
reaction that changes the absorption and emission capabilities, becoming non-fluorescent (85, 
86). Advanced microscopy methods such as DV and SIM require photo-stable dyes for optimal 
image reconstruction. Thus, in these methods photobleaching hampers the quality of the 
reconstructed image. Furthermore, the broad emission spectra of autofluorescence pose a 
challenge in computationally-based microscopy techniques such as DV and SIM. Additionally, 
in the case of live-cell imaging, a process called phototoxicity will also limit the imaging 
acquisition. In live processes, prolonged exposure of cells to light leads to chemical reactions 
that alter the biochemistry of the samples (86-88). 
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2 Materials and methods  
In this project, full-term human placenta from healthy pregnancies and women with 
preeclampsia were used to investigate suitable placental biomarkers for ultrastructural and 
subcellular detection of the protein-specific signal associated with preeclampsia. FFPE and 
cryopreservation techniques were used to prepare and preserve the tissue specimens (Figure 
8). Placental samples were collected, preserved, sectioned, immunofluorescence-labeled, and 
investigated using advanced fluorescence optical microscopes. Table S1 in Supplementary 
provides a detailed list of all the equipment, reagents and solutions used for the study. The 
labeling experiments with the different combinations of markers are presented in Table S2 in 
Supplementary. 
 
Figure 8 Schematic overview of sample preparation protocols for advanced fluorescence microscopy of 
placental tissue.(A) FFPE tissue sections sample preparation procedure. (B) Cryopreserved tissue section 
preparation procedure. (C) Different advanced fluorescence microscopy methods were performed to generate 
images, including the Olympus VS120 whole-slide scanner, the DV microscope, and the OMX microscope. From: 
Villegas-Hernández et al., 2020 with permission from Villegas-Hernández.  
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2.1 Clinical evaluation of full-term placentas 
Clinical evaluation of the normal and preeclamptic full-term placentas were performed by 
clinicians at the University Hospital of Northern Norway (UNN) (89) following the Norwegian 
guidelines for diagnosis at the Department of Obstetrics and Gynaecology.  
 
2.2 Collection of human placental tissue samples  
Full-term placentas from normal and preeclamptic patients were collected as referred to in 
Table 1. For optimization, normal (n=2) and PE (n=2) placenta samples and for morphological 
investigation, normal (n=6) and PE (n=6) samples were collected immediately after delivery 
(within 30 minutes). The study was approved by the Regional Committee for Medical and 
Health Research Ethics-North Norway (REK Nord ref.# 2010/2058-4). The written consent was 
obtained from the participants. All the samples were anonymized. 
Table 1 Overview of full-term placentas from Caucasian patients used for this study. 
Human term placenta For optimization  For investigation   
FFPE sections Normal (n=1) PE (n=1) Normal (n=5) PE (n=5) 




2.3 Tissue preparation of FFPE sections  
2.3.1 Formalin fixation  
The collected placenta tissues were processed following standard histological procedures. The 
tissue processing was performed by the bioengineer at the pathology department. Tissue 
fixation is crucial for obtaining the high-quality morphology needed for targeting and 
identifying structures of interest in histopathological diagnosis and analysis. Tissue fixation 
entails a series of complex chemical modifications of macromolecules in tissues to preserve 
their structure and chemical composition as close to their natural state (90, 91). It prevents 
autolysis, mitigates putrefaction and preserves the morphology while maintaining antigenicity 
(63). The human placental tissues were quickly submerged in formalin fixative after the biopsy 
to prevent autolytic degradation by proteolytic enzymes and contamination within the tissue 
(91). The formalin fixative is commonly used in pathology examination because of its degree 
of accuracy and adaptability (91). Longer fixation of the tissue may harden the further 
processing of paraffin infiltration, which may hamper the quality of sectioning. Thus, this 
procedure was vital for acquiring adequate tissue sections. 
2.3.2 Dehydration, paraffin embedding and sectioning 
After fixation, the tissue specimens were further processed for dehydration with graded ethanol 
and Xylene to remove the water. Thereafter, the tissue was infiltrated with an infiltration agent 
(molten paraffin wax) to remove Xylene from the dehydration step before embedding in 
paraffin which permits the tissue to be cut into thin sections. This process solidified and formed 
a hard matrix which was then cut into semi-thin sections of 4-5µm thickness using a microtome 
(HM 355S Automatic Microtome, Thermo Fisher Scientific, Waltham, Massachusetts, USA). 
With co-assistance and training from a histo-technologist, adequate paraffin blocks of FFPE 
were sectioned into 4 µm thickness and mounted on a microscope glass slide.  
2.3.3 Deparaffinization and rehydration  
The tissue sections were incubated at 60oC overnight before performing deparaffinization and 
rehydration. Incubation overnight was performed to obtain good adhesion of the sample to the 
slide including melting the substantial amount of paraffin. Overnight incubated tissue sections 
were then deparaffinized in Xylene (3 x 10 minutes) and rehydrated in graded alcohol:100% 
ethanol (2 x 10 minutes), 96% ethanol (2 x 10 min), 70% Ethanol (10 minutes). Xylene is a 
flammable toxic organic solvent that is commonly used to solubilize paraffin for 
deparaffinization of the tissue sections. The series of degraded alcohol concentration solutions 
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removed Xylene and reintroduces the water molecule into the tissue. The deparaffinized and 
rehydrated tissue sections were washed with 150mM glycine bleaching solution (30 minutes) 
to neutralize free aldehydes in the tissue and enhance the binding capabilities of the antibodies 
and dyes to the sample. Lastly, the FFPE sections were washed with MilliQ-water (5 minutes) 
to remove the bleaching solution.  
2.3.4 Antigen retrieval  
Following deparaffinization and rehydration, antigen retrieval was performed using citrate 
buffer (pH 5.98) which enabled the antibodies to access the target proteins within the tissue and 
separate the crosslinks that were formed during fixation (63). This technique was highly 
beneficial to restore epitope-antibody reactivity. The citrate buffer solution was pre-warmed to 
around 95°C (10 minutes), and the samples were placed in a glass-beaker filled with hot buffer. 
The glass-beaker containing tissue sections were microwaved (2 x 5 minutes) at 50% power 
(filled up with hot buffer in between if the level got low). Thereafter, the sections were cooled 
down in the buffer solution (20 minutes) at room temperature.  
2.3.5 Immunofluorescence labeling  
After antigen retrieval, immunofluorescent labeling was employed. The FFPE sections were 
washed with MilliQ-water (3 x 2 minutes) and washing buffer (TBST; 1X TBS and 0.05% 
Tween 20) (2 minutes) before incubating in a blocking buffer (1% BSA in TBST) (30 minutes) 
at room temperature. Blocking buffer prevents the unspecific binding of antibodies in the tissue 
sections. Primary and secondary antibodies were prepared by diluting in blocking buffer 
according to the optimized concentrations shown in Table 3 (Table S2 in Supplementary). The 
slides were then placed in a wet chamber to avoid drying of the sample during incubation and 
started with applying primary antibody on the slide and incubated overnight at 4°C.  
After overnight incubation, the FFPE slides were washed with washing buffer/TBST (3 x 5 
minutes) and PBS (2 x 5 minutes) before secondary incubation (1 hour) at room temperature. 
All steps from labeling with secondary antibodies were performed under aluminum foil to 
prevent photobleaching. Thereafter, proceed with washing buffer/TBST (3 x 5 minutes) and 
PBS (2 x 5 minutes) washing step. Direct fluorescent labeling was used in combination with 




Figure 9 Sample preparation for FFPE sections using indirect labeling technique. Enlarged and modified image 
from Figure 8. 
 
2.3.6 Direct fluorescence labeling  
Figure 10 represents the preparation of fluorescence labeling for FFPE sections. For 
fluorescence labeling, antigen retrieval was not included as fluorescence dyes can bind to the 
target structure directly. The following steps were performed under aluminum foil to prevent 
photobleaching of the fluorescence dyes. After deparaffinization and rehydration, the FFPE 
samples were directly incubated with phalloidin-Atto 647 N for F-actin staining (15 minutes), 
then washed with PBS (2 x 5 minutes) before labeling with CellMask Orange (CMO) for 
membrane staining (15 minutes). The slides were again washed with PBS (2 x 5 minutes) and 
then incubated in DAPI for nuclei staining (15 minutes). The labeled slides were finally washed 
with MilliQ water (2 x 5 minutes) to remove any dyes left on the slide. The FFPE samples were 
thereafter mounted and sealed according to section 2.3.8. 
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Figure 10 Sample preparation for FFPE sections using direct labeling technique. Enlarged and modified image 
from Figure 8. 
 
2.3.7 Multiple immunofluorescence labeling  
In addition to direct and indirect labeling techniques, multiple labeling technique (MLT) was 
also performed and optimized for FFPE- and cryo-sections. This technique is widely used to 
identify co-localization, different cell populations, or to obtain multiple antigen localization 
within the tissue or sample. However, some criteria were required in multiple labeling using 
the indirect method. It involved using primary antibodies and secondary antibody conjugates 
raised in different species of animals to successfully get the result without cross-reaction 
complications. The other criteria were to use secondary antibodies conjugated to different 
fluorochromes (92). For this study, the first labeling technique (mixed technique) implied 
mixing two primary antibodies and labeling the tissue section before incubation overnight 
(Figure 11).  Thereafter, the tissues were labeled with mixed secondary antibodies and 
incubated for 1 hour. The second technique (sandwich technique) indicated labeling with one 
biomarker before labeling with the second biomarker according to Figure 11. The labeled FFPE 
sections were thereafter mounted and sealed according to section 2.3.8. 
25 
 
Figure 11 Schematic representation of two types of multiple labeling techniques. The first technique is called 
the mixed technique: mixing two biomarkers in one solution and labeled them together. The second technique is 
called the sandwich technique: labeling with one biomarker before labeling with the second biomarker. Schematic 
image made with BioRender.com. 
 
2.3.8 Mounting and sealing  
The excess liquid of the FFPE glass slides with the labeled tissue sections was aspirated and 
mounted with Prolong Gold to prevent photobleaching and to closely match the refractive index 
of the objective lens. The mounted slides were then covered with #1.5 Poly-L-Lysine coated 
coverslips and sealed with dental glue Picodent twinsil 22 (1:1 mixture of solution A and B). 
Then, stored at 4 °C protected from the light until further use.  
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2.4 Tissue preparation of cryosections  
The cryo-sections were prepared using the Tokuyasu method. The Tokuyasu method is a simple 
protocol that includes simple chemical fixation, snap-freezing in presence of sucrose, cutting 
into 100-400 nm cryo-sections, then labeling and storage at 4oC until further use (93, 94). 
2.4.1 Fixation of cryosections 
The collected tissues (REK Nord ref.# 2010/2058-4) were macro-dissected approximately 3 cm 
beside the umbilical cord on the fetal side and 3 cm from the peripheral side at the maternal 
side to obtain the maternal and fetal side of the placenta tissue (48, 95). The placental samples 
were rinsed with 9 mg/mL sodium chloride to remove the remaining maternal blood and frozen 
at high pressure (EMPACT 2 HPF; Leica Microsystems, Vienne, Austria) to prevent 
crystallization of ice (more details Nystad et al., 2014 (48)). Tissue samples were infiltrated in 
5 mL of 1 x PIPES-HEPES-EGTA-Magnesium sulfate (PHEM) buffer (see Table S1 for 
chemicals used to make the 1x PHEM buffer). PHEM is a non-toxic buffer (pH 6.96) used for 
preserving the cell structure as it gives better ultrastructural preservation by stopping the 
enzymes from digesting the tissue (96). Placental samples were further dissected into 1 mm3 
and immersed in 5 mL 8% paraformaldehyde (PFA) in PHEM buffer and incubated at 4oC 
overnight (94).  
2.4.2 Storage in liquid Nitrogen 
The overnight fixed tissue samples were washed in 5 mL 1M PBS (2 x 5 minutes) following 
immersion in 12% gelatine at 37 oC in a Tube Rotator B7925 (Agar Scientific Ltd.) for 1 hour. 
The 12% gelatine immersed tissue samples were incubated in 0.12% glycine and infiltrated in 
1 mL 2.3 M sucrose overnight at 4oC on a tube rotator to avoid crystallization during the 
freezing process. The samples were assembled into specimen pins and stored in liquid Nitrogen. 
Before transferring the tissue sample to the pin, a small drop of 2.3 M sucrose was applied to 
each specimen pin to enhance attachment of the specimen and placed in cryogenic vials before 
storage in a liquid nitrogen tank. 
2.4.3 Cryo-sectioning 
To obtain high-quality cryo-sections, an experienced engineer cut the snap-frozen samples into 
100-400 nm thick slices using a cryo-ultramicrotome (EMUC6 ultramicrotome, Leica 
Microsystems, Vienna, Austria). The sectioned samples were collected with a wire loop and 
transferred on #1.5 Poly-L-Lysine coated coverslips. Sucrose infiltration was performed to 
prevent crystallization into ice by disrupting the water molecule interaction. This was 
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performed by applying 2% methylcellulose and 2.3 M sucrose on the tissue specimen placed 
on the coverslips to prevent structure collapse, shrinking, and minimize cell deformation. The 
sections were then placed on a parafilm-covered clean petri dish for storage at 4°C until further 
use.  
2.4.4 Immunofluorescence labeling  
Figure 12 represents the protocol for immunofluorescence labeling on cryo-sections. The cryo-
sections were prepared on a parafilm-covered metal plate. To make sure the methylcellulose-
sucrose mixture was dissolved, the coverslips were warm washed with PBS (3 x 20 min) on a 
heating plate at 40°C. The immunofluorescence labeling protocol was performed at room 
temperature and started with incubating the tissue in blocking buffer (30 minutes), washed in 
PBS (2 x 5 minutes), incubated in primary antibody (1 hour) and then washing with PBS (2 x 
5 minutes). All steps from labeling secondary antibodies were performed under aluminum foil 
to prevent photobleaching. The tissue sections were incubated in secondary antibody (1 hour) 
at room temperature and washed with PBS (2 x 5 minutes). The sections were then labeled with 
CMO and DAPI via direct fluorescent techniques to visualize the membranes and nuclei, 
respectively. Thereafter, the labeled cryo-sections were washed with MilliQ-water (2 x 5 




Figure 12 Sample preparation for cryo-sections using indirect labeling technique. Enlarged and modified image 
from Figure 8. 
 
2.4.5 Direct fluorescence labeling 
Figure 13 represents the protocol for fluorescence labeling on cryo-sections. The labeling 
process for the cryo-sections was similar to the FFPE fluorescent labeling technique. The same 
reagents and dyes were used including the dye concentration presented in Table 3. Direct 
fluorescence labeling started with incubation in phalloidin-Atto 647 N (10 minutes), then 
washed with PBS (2 x 5 minutes) before labeling with CMO (10 minutes). The cryo-sections 
were washed again with PBS (2 x 5 minutes) and incubated in DAPI (10 minutes). The labeled 
sections were then washed with MilliQ-water (2 x 5 minutes) and prepared for mounting and 
sealing according to section 2.4.6. 
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Figure 13 Sample preparation for cryo-sections using direct labeling technique.  Enlarged and modified image 
from Figure 8. 
 
2.4.6 Mounting and sealing 
The excess liquid from the cryo-sections were aspirated before mounting with Prolong Gold 
Antifade Mountant in the center of the microscopy glass slide and placed the sample facing the 
mounting medium. The excess mounting medium was removed by tapping gently on top of the 
slides and aspirated the excess on the edges of the coverslip. The visible air bubbles were also 
removed by tapping gently with a plastic tweezer. The slides with the sample on were then 
sealed with dental glue Picodent twinsil 22 (1:1 mixture of solution A and B) and stored at 4°C 




For this study, 3 advanced fluorescence microscopes were used. The Olympus VS120 whole-
slide scanner Microscope (Olympus Life science, Massachusetts, USA), the DeltaVision Elite 
High-resolution Microscope (GE Healthcare, Chicago, USA), referred to as DV microscope, 
and the DeltaVision OMX V4 Blaze (GE Healthcare, Chicago, USA), referred to as the OMX 
microscope. The Olympus and DV microscopes were used to acquire a large field of view 
(FOV) fluorescent images, whereas the DV and the OMX microscopes were used to generate 
high-resolution (deconvolution) and super-resolution (SIM) images, respectively.  
2.5.1 Whole-slide scanner 
Olympus VS120 is a whole-slide scanning microscope that allows multicolor imaging of 
fluorescently-labeled samples in manual and automated mode (97). For a large field of view 
(FOV), a 20X/NA 0.75 objective lens (Olympus, Tokyo, Japan) was used. The image 
acquisition was performed by a specialized technician at the Advanced Microscopy Core 
Facility, UiT. Further, whole-slide scanning images were reconstructed and processed using 
Olympus Soft Imaging Solution GmbH software.  
2.5.2 DV and OMX 
The labeled slides were gently cleaned with 70 % ethanol to make sure the coverslip was dust-
free and cleaned before microscopy. The labeled and non-labeled samples were imaged on the 
DV microscope with four channels (Table 2). Started with a 20X/NA 0.75 objective lens to 
generate a large FOV. Then, progressively increased the magnification to 60X/NA 1.42 oil-
immersion objective lens to identify regions of interest (ROI). Used the same coordinates of 
the ROI on the OMX microscope with 60X/NA 1.42 oil-immersion objective lens, three 
sCMOS cameras, including four channels to obtain high-resolution and super-resolution 
microscopy images.  
Table 2 Overview of excitation wavelength and emission filter for the four channels in the OMX microscope.  
Channels  Excitation wavelength [nm] Emission filter [nm] 
Channel 1 642 683/40 
Channel 2  568 609/37 
Channel 3 488 528/48 
Channel 4 405 436/31 
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To ensure that the refractive index of the immersion oil matched that of the coverslip, a PSF 
optimization was required. PSF optimization was carried out by orthogonal visualization of 
single emitters on diverse z-stacks acquired with immersion oils of different refractive indices 
(S4 in Supplementary). The PSF of single emitters was monitored in the orthogonal view of the 
constructed images until symmetrical shapes were obtained. This was essential as a mismatch 
can lead to artifacts in the reconstructed images. Following, the generated images were 
reconstructed and processed using SoftWoRx and Fiji, respectively.  
 
2.6 Autofluorescence controls 
A test to visualize the autofluorescence was performed by following all the steps except labeling 
on a normal FFPE- and cryo-sections. The unlabeled normal healthy placenta sections were 
mounted and sealed according to section 2.3.8 and section 2.4.6, respectively. The FFPE- and 
cryo-sections were then imaged using the DV microscope with a 20X/NA 0.75 objective lens. 
Autofluorescence control was performed to evaluate and control the fluorescence dyes and their 
excitation ratio. 
 
2.7 Quantitative analysis 
The quantification analysis was performed on placental features independently localized using 
large FOV images generated from Olympus VS120 microscope and DV microscope. A grid 
was placed above the large FOV image. Then, the placental features were counted on each box 
using naked eyes (Figure 14). 
 
 
Figure 14 Methodology for quantitative analysis.  The quantitative measurements of placental features were 
characterized by using a large field of view (FOV) image. A grid was placed above the large FOV image. The 
placental features were identified by counting the presence of the features in each box with naked eyes.  
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3 Results  
The results were obtained from two stages of research (Figure 15). Stage 1 included 
optimization of the methods for FFPE- and cryo-sections which was 75% of the research time. 
The placenta samples of FFPE sections (normal n=1 and PE n=1) and cryo-sections (normal 
n=1 and PE n=1) were used for the optimization stage. DV microscope and OMX microscope 
were used to generate large FOV, high-resolution (DV) and super-resolution (SIM), 
respectively, for quality and optimization control of the labeled sections. Stage 2 took 25% of 
the research time. This part included morphology study of FFPE sections from normal (n=5) 
and PE (n=5) using the Olympus VS120 microscope and the DV microscope to generate large 
FOV and high-resolution images, respectively. Large FOV was also used for quantitative 
analysis. The cryo-sections of normal (n=1) and PE (n=1) were used to investigate subcellular- 
and ultrastructure in high-resolution (DV) and super-resolution (SIM) images generated by the 
OMX microscope. The morphological investigation was performed using different biomarkers 
to analyze the morphological and quantitative differences comparing placentas from healthy 
pregnancies and pregnancies of preeclamptic women.  
 
Figure 15 Experimental plan of the master project. Flowchart representing two stages of the master project. 
Stage 1 included optimization of the methods on FFPE- and cryo-sections and occupied 75% of the research time. 
Large FOV and high-resolution images were generated using DV microscope and OMX microscope for super-
resolution images. Stage 2 of the study was the morphology investigation of labeled FFPE sections and cryo-
sections using Olympus VS120 and DV microscope for generating large FOV and high-resolution (DV) images, 
respectively. Whereas OMX microscope was used for generating super-resolution (SIM) images. Stage 2 of the 
thesis took 25% of the research time.  
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3.1 Autofluorescence characterization  
Autofluorescence was observed in the human placental FFPE sections (Figure 16) and cryo-
sections (Figure 17) in all the fluorescent channels of the microscope, with maximum signal 
strength (50%  excitation intensity and 50  acquisition time). More details of excitation 
wavelength and emission filters for the different channels are presented in Table 2. Natural 
autofluorescence responses from maternal and fetal red blood cells were observed in all 
channels in the FFPE section but not in the cryo-section.  
  
Figure 16 Autofluorescence control of unlabelled FFPE placenta section.  A normal placenta section of 4 µm 
thickness was used for observation of the autofluorescence response in the four channels. The channels were set 
to 50% excitation intensity and 50ms acquisition time. Channel 1(yellow) with excitation wavelength 642 nm and 
the emission filter 683/40nm. Channel 2 (magenta) with excitation wavelength 568nm and emission filter 
609/37nm. Channel 3 (cyan) with excitation wavelength 488nm and emission filter 528/48mn. Channel 4 (blue) 
with excitation wavelength 405 nm and emission filter 436/31 nm. Natural autofluorescence was observed from 
fetal and maternal red blood cells in all channels. 
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Figure 17 Autofluorescence control of unlabelled cryo- placenta section.  A normal placenta section of 400 nm 
thickness was used for observation of the autofluorescence response in the four channels. The channels were set 
to 50% excitation intensity and 50ms acquisition time. Channel 1(yellow) with excitation wavelength 642 nm and 
the emission filter 683/40nm. Channel 2 (magenta) with excitation wavelength 568nm and emission filter 
609/37nm. Channel 3 (cyan) with excitation wavelength 488nm and emission filter 528/48mn. Channel 4 (blue) 
with excitation wavelength 405 nm and emission filter 436/31 nm. 
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3.2 Optimization of concentration and incubation times of 
markers for FFPE and cryo-sections 
Optimization of biomarkers and incubation times of each marker on FFPE- and cryo-sections 
was required to obtain adequate quality for high-resolution and super-resolution microscopy. It 
was a lengthy process that took 75% of the research time for this study. Optimized 
concentrations and incubation times are presented in Table 3. The optimized concentrations of 
the different markers were the same for FFPE- and cryo-sections, whereas the optimized 
incubation times were different. The optimization of the placental biomarkers included 
laeverin, CK-7 and PLAP, as well as fluorescent markers non-specific to placentae such as 
phalloidin-Atto 647N, CMO and DAPI.  
 
 
Table 3. List of optimized concentrations and incubation times of markers used in this study for FFPE sections 
and cryo-sections. 



















Overnight  1 hour  
CK-71 hTB5 
cytoplasm 
1:100 Overnight  1 hour  
PLAP2 hSTB6 
microvesicles 










Atto 647 N 

















2PLAP: Placental alkaline phosphatase 
3CMO: CellMask Orange 
4DAPI: 4′,6-diamidino-2-phenylindole 
5hTB: human trophoblast cells 
6hSTB: human syncytiotrophoblast  
7BB: Blocking buffer 
8PBS: Phosphate-buffered Saline 
9FFPE: Formalin-fixed paraffin-embedded 
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An example of the optimization process for PLAP is shown in Figure 18, where cryo-sections 
were labeled with PLAP (yellow), CMO (magenta), and DAPI (cyan) (see reference #1 in 
Table S2 in Supplementary). Cryo-tissue sections were labeled with different concentrations 
of PLAP antibody (namely 1:50, 1:100, 1:500, and 1:1000). The strongest signals were 
observed from PLAP 1:50 concentration, compared with the other dilution (1:100 
concentration), thus used for comparisons of healthy and PE tissue sections.  
 
 
Figure 18 Concentration optimization for PLAP in cryo-sections of healthy placentas.  Syncytial microvesicles 
stained with PLAP (yellow), membrane stained with CMO (magenta), nuclei staining with DAPI (cyan). One cryo-
section of 4 µm thickness was labeled with 1:50 concentration, and the second cryo-section was labeled with 1:100 
concentration. The strongest signals were detected from 1:50 concentration compared with the 1:100 
concentration. FC: fetal capillary, hCTB: human cytotrophoblast cells, hSTB: human syncytiotrophoblast. CMO: 
CellMask Orange, DAPI: 4′,6-diamidino-2-phenylindole, PLAP: placental alkaline phosphatase. 
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3.3 Optimization of multiple labeling technique  
In addition to improvement and optimization of biomarker concentrations and incubation times, 
optimization of the multiple labeling technique (MLT) was also part of this study. MTL was 
investigated to obtain high-quality and optimal labeling using two different biomarkers in the 
same placental tissue sample. Normal placenta FFPE tissue sections of 4 µm thickness were 
labeled using the mixed technique and the sandwich technique of MLT (see Figure 11 and 
reference #2 in Table S2 for details). High-resolution images were generated using a DV 
microscope with a 60X/NA 1.42 oil-immersion objective lens. The experiment showed similar 
results for both techniques using laeverin and CK-7 as biomarkers focusing on the 
syncytiotrophoblast membrane of the chorionic villi (Figure 19). The sandwich technique 
included 3 days of preparation, whereas the mixed technique was only 2 days of preparation. 




Figure 19 Two different multiple labeling techniques were performed on 4µm thick FFPE normal healthy 
placenta sections. Mixed technique: a high-resolution deconvolved image of syncytiotrophoblast located at the 
terminal villi in normal healthy human placenta tissue with 60X magnification using mixed labeling technique. 
Sandwich technique: high-resolution deconvolution image of syncytiotrophoblast in normal healthy human 
placenta tissue of the same magnification using the sandwich labeling technique. Laeverin (yellow), CK-7 
(magenta), and nuclei (cyan). DAPI: 4′,6-diamidino-2-phenylindole, MLT: multiple labeling technique, CK-7: 
cytokeratin-7.   
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3.4 Large FOV imaging of chorionic villi  
The FFPE placenta tissue sections of 4 µm thickness from normal (n=5) and PE (n=5) placentas 
were immunofluorescence-labeled with CK-7 (green) for human trophoblast cytoplasm 
staining, CMO (red) for membrane staining and DAPI (blue) for nuclei staining (see reference 
#3 in Table S2). A large FOV was generated using a DV microscope with a 20X/NA 0.75 
objective lens (Figure 20). Various parts of chorionic villi such as stem villi (SV) and terminal 
villi (TV) were observed in both healthy (Figure 20A) and preeclamptic (Figure 20B) 




Figure 20 Large FOV of normal and PE human chorionic villi. (A) A large FOV image of a normal placenta 
with a 20X/NA 0.75 objective lens. (B) A large FOV of a preeclamptic placenta with a 20X/NA 0.75 objective lens. 
Human trophoblast cytoplasm was stained with CK-7 (green), membrane stained with CMO (red), and nuclei 
counterstained with DAPI (blue). CK-7: cytokeratin-7, DAPI: 4′,6-diamidino-2-phenylindole, FOV: field of view, 
SV: stem villi, TV: terminal villi, arrowhead: syncytial knots. 
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3.4.1 Actin filament spots found in chorionic villi  
The FFPE placenta tissue sections of 4 µm thickness from normal (n=5) and PE (n=5) placentas 
were direct fluorescence-labeled with phalloidin-Atto 647 N (magenta), CMO and DAPI (blue) 
for actin, membrane and nuclei staining, respectively, according to reference #4 in Table S2 in 
Supplementary. The large FOV images generated by Olympus VS120 with 20X/NA 0.75 
objective lens not only provided an overview of the chorionic villi (hCV) but also revealed actin 
filament localization in the preeclamptic placenta tissue section (Figure 21). For better 
visualization of the morphology, the CMO channel was turned off in Figure 21. F-actin 
filaments were observed at the basement membrane of the chorionic villi and in the terminal 
web regions of the placenta villi in both normal (Figure 21A,B) and PE placentas (Figure 
21C,D). Additionally, several actin filament spots were observed randomly and independently 
localized at the hCV in both normal (Figure 21A) and PE sections (Figure 21C). 
 
Figure 21 F-actin filament present in 4 µm thick normal and PE chorionic villi. F-Actin labeled with phalloidin-
Atto 647 N (magenta), and nuclei counterstained with DAPI (blue). (A-D) Olympus VS120 images with 20X/NA 
0.75 objective lens. (A) Normal FFPE section. Actin spots are located randomly and independently of each other 
in the chorionic villi. (B) A magnified region from (A). F-actin is located in the basement membrane of hCV and 
actin spots are also identified. (C) Preeclamptic FFPE section. Actin spots are located randomly and 
independently of each other in the chorionic villi. (D) A magnified region from (C). F-actin is located in the 
basement membrane of hCV and actin spots are also identified. DAPI: 4′,6-diamidino-2-phenylindole, FOV: field 
of view, SV: stem villi, TV: terminal villi, hCV: human chorionic villi, hSTB: human syncytiotrophoblast. 
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3.4.2 No significant differences of actin spots in normal and PE 
placentas  
Quantitative analysis was performed to identify the number of actin spots present in normal and 
PE placenta tissues. The analysis was performed according to Figure 14. The quantitative 
measurement was performed to understand the specific localization of actin spots expression. 
Table 4 represents the quantitative analysis of actin spots localized randomly and 
independently in normal and PE chorionic tissues. The actin spots were identified in different 
subtypes within the chorionic villi in both normal (n=5) and PE (n=5) placenta tissue sections. 
The p-value was estimated using Student’s t-test. The mean p-value was higher than 0.05 for 
the actin spots localization in the different subtypes in the chorionic villi. This indicates no 
significant difference between normal and PE placentas. 
 





Normal (n=5)  PE5 (n=5) P value  
TV1 146  178 0.55 
MIV2 46 21 0.50 
IIV3 12 27 0.54 
SV4 44 76 0.47 
1TV: Terminal villi  
2MIV: Mature intermediate villi  
3IIV: Immature intermediate villi  
4SV: Stem villi  




3.4.3 An increased amount of syncytial knots in PE 
A quantitative study of syncytial knots presence in PE and normal chorionic villi was identified 
by naked eyes according to Figure 14. The FFPE samples of normal (n=5) and PE (n=5) 
placenta were labeled using CK7 (green), CMO (red), and DAPI (blue) according to reference 
#3 in Table S2 in Supplementary. Large FOV images of immunofluorescent-labeled normal 
(n=5) placenta sections and PE (n=5) placenta sections were used to quantify the syncytial 
knots. Table 5 represents the number of syncytial knots quantified. In normal placentas were 
427 syncytial knots identified, whereas 689 syncytial knots were present in PE placentas. The 
mean p-value of 0.015 was estimated using Student’s t-test. The p-value is lower than 0.05 
which indicates that there are significant differences between PE and normal placentas. 
 
Table 5 Overview of the number of syncytial knots observed in normal and preeclamptic term placentas. 
 Mean value 
Normal (n=5) PE2 (n=5) P value  
SK1  427 689 0.015 
1SK: Syncytial knots 
2PE: Preeclamptic placenta  
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3.5 Different contrast from FFPE- and Cryo-section 
Healthy full-term placenta of FFPE sections of 4 µm thickness and cryo-section of 400 nm 
thickness were labeled using phalloidin-Atto 647N (yellow), CK-7 (magenta) and DAPI (cyan) 
(see reference #5 in Table S2). Microscopy images of the tissue sections were generated using 
the DV microscope with a 60X/NA 1.42 oil-immersion objective lens to obtain high-resolution 
images. The representative images of the FFPE section and cryo-section are presented in Figure 
22. The high-resolution images allowed for observation of placental compartments such as 
terminal villi (TV), human syncytiotrophoblast (hSTB) and fetal capillaries (FC) in both 
sections. The FFPE section showed background signals and artifacts including decreased 
contrast (Figure 22A), whereas enhancement of contrast and signal detection was observed in 
the cryo-sections (Figure 22B). Additionally, finer structural details were observed in the cryo-
section image compared to the FFPE images.  
 
 
Figure 22 High-resolution deconvolved image of normal placental chorionic terminal villi.  F-actin stained with 
phalloidin-Atto 647 N (yellow), CK-7 (magenta), and nuclei labeled with DAPI (cyan). High-resolution image 
generated by DV microscope with 60X/NA 1.42 oil-immersion objective lens. TV, hSTB, and FC were identified 
in both sections. (A) High-resolution image of FFPE section. (B) High-resolution image of cryo-section. Contrast 
and signal enhancement in cryo-section compared to FFPE-section. DAPI: 4′,6-diamidino-2-phenylindole, CK-
7: cytokeratin-7, FC: fetal capillaries., hSTB: human syncytiotrophoblast, TV: terminal villi. 
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3.6 High-resolution vs super-resolution of chorionic villi 
PE human placenta cryo-section of 100 nm thickness was labeled using CMO (magenta) and 
DAPI (cyan) (see reference #6 in Table S2). High-resolution (DV) and super-resolution (SIM) 
images were generated using an OMX microscope with a 60X/NA 1.42 oil-immersion objective 
lens (Figure 23). Microscopy images of DV (Figure 23A) and SIM (Figure 23B) allowed for 
visualization of chorionic villi morphology in PE placenta tissues. The DAPI channel was 
turned off due to better visualization of the membrane structures. The images show membrane 
staining in magenta.  
DV and SIM images show similar results in terms of signal detection and contrast of the 
placental tissues. Placental features were identified in both images such as hSTB, syncytial 
plasma membrane and fetal capillaries (FC) located inside the chorionic villi. The high-
resolution images were generated by deconvolution. The DV images show great contrast and 
signal detection. Super-resolution images were generated by SIM reconstruction. The SIM 
images show enhancement in contrast and resolution, allowing the identification of subcellular 
structures such as the syncytial microvilli brushborder located at the apical surface of the 
syncytial plasma membrane (Figure 23D). In comparison, these features are not discernible on 
the DV images (Figure 23C).  
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Figure 23 Comparison of high-resolution and super-resolution of hSTB in PE placenta tissue. DV images and 
SIM images generated by OMX microscope with 60X/NA 1.42 oil-immersion objective lens. Membrane staining 
in magenta. (A) DV images of hCV in PE placenta. (B) SIM image of hCV in PE placenta. (C) Magnified DV 
image of the boxed region in (A). High-resolution and contrast enhancement is obtained, hence structures not 
easily distinguishable (D) Magnified SIM image of the boxed region in (B). SIM image allows for higher resolution 
and structural observation of placental membrane which allows for visualization of chorionic microvilli. FC: fetal 
capillary, hSTB: human syncytiotrophoblast cells, hCV: human chorionic villi.   
45 
3.7 Microvilli identified by super-resolution imaging  
Normal and PE placenta cryo-sections of 100 nm thickness were direct fluorescent-labeled with 
CMO and DAPI according to reference #6 in Table S2 in Supplementary. The reconstructed 
SIM images were generated using an OMX microscope with a 60X/NA 1.42 oil-immersion 
objective lens. Super-resolution images were generated and the representative image show 
membrane staining in magenta (Figure 24). The contrast enhancement provided by SIM allows 
for a clearer observation of placental morphology. The membranes and nuclear structures are 
well observed in the representative image. The structures of membranes are easily 
distinguishable and allow for fine details in the magnified images (Figure 24C-D). 
The SIM images show human chorionic villous in normal (Figure 24A) and PE (Figure 24B) 
placentas. Fetal capillaries (FC) and human syncytiotrophoblast (hSTB) are identified. SIM 
images allow the visualization of ultrastructural details of the placental morphology. The 
magnified images from Figure 24A and Figure 24B show normal syncytial plasma membrane 
and PE syncytial plasma membrane, respectively. The magnified images allow for observing 
chorionic microvilli (arrow) located at the brushborder of the hSTB in normal (Figure 24C) 
and PE placentas (Figure 24D). The microvilli are located at the apical surface of the syncytium 
which physiologically is in direct contact with the maternal blood. The arrows point to the area 





Figure 24 Super-resolution of chorionic villi in normal and PE placenta. CMO was used for membrane staining 
(magenta). (A) 100 nm thick cryo-section of the normal placenta. (B) 100 nm thick cryo-section of PE placenta. 
(C) Enlarged image from (A) showing normal plasma membrane of hSTB and syncytial microvilli located at the 
surface of the plasma membrane. The arrow represents the localization of microvilli at the apical surface of 
normal villi. (D) Enlarged image from (B) showing PE plasma membrane of hSTB and syncytial microvilli located 
at the surface of the plasma membrane. The arrow represents the localization of microvilli at the apical surface 
of PE villi, where it seems to be disorganized compared to the healthy microvilli. CMO: CellMask Orange, FC: 
fetal capillary, hSTB: human syncytiotrophoblast.  
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3.8 PLAP expression observed in microvesicles at the 
microvilli brushborder 
Reconstructed SIM image of normal cryo-section of 400 nm thickness was 
immunofluorescence labeled with CMO (magenta), PLAP (yellow) and DAPI (cyan) according 
to reference #1 in Table S2 in Supplementary. The representative image was generated using 
the OMX microscope with a 60X/NA 1.42 oil-immersion objective lens to perform SIM 
reconstruction. The representative images identify mature intermediate villous (MIV) and 
terminal villous (TV) within a normal placental tissue (Figure 25). In addition, placental cells 
were also identified, such as human and syncytiotrophoblast (hSTB), which are located in MIV 
and TV. The super-resolution image allowed for observing PLAP expression in normal 
chorionic villi. Increased signal detection from PLAP (yellow) was observed at the apical 
surface of the syncytial plasma membrane border of MIV and TV. The SIM image of 400 nm 
thick cryo-section did not allow for structural detailed observation as observed in the previous 




Figure 25 PLAP expression located at the apical syncytial trophoblast membrane of healthy chorionic villi.   
Cryo-section of normal placenta labeled with CellMask Orange for membrane staining (magenta), PLAP for 
syncytial microvesicles (yellow), and DAPI for nuclei staining (cyan). Imaged using SIM with 60X/NA 1.42 oil-
immersion objective lens. PLAP expression is observed in the syncytial microvesicles localized at the brushborder 
of hSTB. Additionally, placental compartments are identified as human syncytiotrophoblast (hSTB), fetal 
capillaries (FC) located inside the mature intermediate villous (MIV), and terminal villous (TV). 
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3.9 Laeverin expression at the apical side of the 
syncytiotrophoblast membrane 
Multiple labeling technique (the mixed technique) was performed using laeverin (green) and 
CK-7 (red) biomarkers on 4 µm thick FFPE normal (n=5) and PE (n=5) sections. The sections 
were counterstained with DAPI (blue) for nuclei staining (see reference #2 in Table S2). The 
whole slide was scanned making images with large FOV (Olympus VS120 with 20X/NA 0.75 
objective lens). Low-resolution with large FOV was obtained for the FFPE sections for the 
morphology study.  
The microscope images appear to show laeverin (green) expression, CK-7 (red) expression and 
nuclei (blue) (Figure 26). Laeverin expression appears to be observed in the apical 
syncytiotrophoblast plasma membrane and CK-7 expression in syncytial cytoplasm in normal 
samples, where colocalization (yellow) of the markers appeared to be observed (Figure 26A). 
In PE samples, the laeverin expression seems to be observed in the syncytial plasma membrane 
and the trophoblast cytoplasm (Figure 26B). Additionally, the microscope observation appears 
to show laeverin expression in the fetal capillary walls in both normal and PE chorionic villi. 
 
 
Figure 26 Laeverin expression in normal and PE hSTB plasma membrane. Human chorionic villi present in 
normal and PE 4µm thick FFPE placenta tissue section. Laeverin expression in the syncytiotrophoblast plasma 
membrane and cytoplasm in green, cytokeratin-7 expressed in hTB cytoplasm in red, and nuclei stained with DAPI 
in blue. Images generated by Olympus VS120 (whole-slide scanner) with 20X/NA 0.75 objective lens. (A) Laeverin 
expression in normal chorionic villi. Laeverin expression appears to be observed in the syncytial plasma 
membrane. Co-localization of laeverin and CK-7 appeared to be observed (yellow) (B) Laeverin expression in PE 
chorionic villi. Laeverin expression seems to be observed in the syncytial plasma membrane and trophoblast 
cytoplasm. Additionally, laeverin expression appeared to be observed in normal and PE fetal capillary walls. CK-
7: Cytokeratin-7, hSTB: human syncytiotrophoblast, FC: fetal capillary, DAPI: 4′,6-diamidino-2-phenylindole. 
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3.9.1 Laeverin expressed in fetal capillaries  
Cryo-sections of 100 nm thickness from normal and PE placentas were immunofluorescent 
labeled with laeverin (yellow) and CMO (magenta) and DAPI (channel turned off in the image) 
according to reference #7 in Table S2 in Supplementary. SIM images were generated using an 
OMX microscope with a 60X/NA 1.42 oil immersion objective lens. In the SIM images, 
contrast enhancement and signal detection from the markers are observed (Figure 27). Fetal 
capillary (FC) and fetal red blood cells (fRBC) in normal and PE chorionic tissue were 
identified in the representative image. The representative images show laeverin expression in 
the fetal capillary wall including on fRBC in the normal placenta (Figure 27A). In PE tissue, 
the laeverin is observed as overexpressed inside the fetal capillary with the presence of fRBC 
inside (Figure 27B).  
 
 
Figure 27 Laeverin expression in the fetal capillary. Normal and PE placenta tissues cryo-sections of 100 nm 
thick labeled with laeverin (yellow), CMO (magenta), and DAPI (turned off) to identify laeverin expression and 
localization. Super-resolution image generated by OMX with 60X/NA 1.42 oil-immersion objective lens. (A) 
Laeverin expression in normal fetal capillary wall. (B) Overexpression of laeverin expression in PE fetal capillary. 
FC: fetal capillary, fRBC: fetal red blood cells, CMO: CellMask Orange, DAPI: 4′,6-diamidino-2-phenylindole.  
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4 Discussion  
In this study, optimization of sample preparation, labeling concentrations and incubation times 
of biomarkers for immunofluorescence labeling was essential for advanced fluorescence 
microscopy methods. The morphological studies included different biomarkers for the 
cytoplasm of human trophoblast cells (CK-7), syncytial membranes (laeverin) and syncytial 
trophoblast-derived microvesicles (PLAP). These biomarkers including direct fluorescence 
dyes (phalloidin-Atto 647 N, CMO and DAPI ) were used for the identification of placental 
subcellular structures and lesions which discriminates between term placentas of healthy 
pregnancies and placentas of women with preeclampsia. 
4.1 The progression during optimization  
4.1.1 Artifacts affected imaging of FFPE sections 
Solid FFPE preservation was a good basis for acquiring high-quality microscope images since 
a vast majority of tissue samples are preserved in paraffin blocks. However, several artifacts 
appeared in the fluorescently stained FFPE slides. Artifacts might have arisen from improper 
fixation, the type of fixative used for the tissue, poor dehydration and paraffin infiltration, 
unsuitable reagents, poor sectioning, poor deparaffinization and rehydration, defective labeling 
technique and/or inadequate oil matching at the imaging site. All of these artifacts vary from 
sample to sample leading to imperfect imaging results. It is not possible to control artifacts that 
stems from the tissue processing, and paraffin-embedding since these were performed by 
different pathologists at different time points. 
One of the poor qualities in imaging at the beginning of the project came from the laboratory 
technique, such as poor deparaffinization and rehydration steps (S3 in Supplementary). Poor 
deparaffinization and rehydration were easily visualized as reduced signal detection, blurriness 
and unclear regions in the imaged FFPE sections. This artifact was improved by a longer 
incubation time (overnight incubation) for the FFPE tissue sections in a 60°C incubator to 
remove the paraffin. To be sure the paraffin is melted properly, a longer incubation time was 
preferred since it was easier to remove the excess paraffin in the deparaffinization and 
rehydration step. In addition, using clean (pure) deparaffinization and rehydration reagents 
instead of reusing the reagents was also preferred to avoid contamination and properly 
removing the paraffin excess. Sufficient removal of paraffin had a major influence on the 
labeling and the imaging result. 
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4.1.2 Limitations with direct fluorescent dyes 
Commercial fluorophores are designed with maximum excitation and emission wavelength 
which allows the researcher to choose an ideal fluorescent dye within these excitation and 
emission wavelengths. However, choosing a fluorophore with poor extinction coefficients and 
quantum yields will lead to fluorophore appearing as dim and might lead to photobleaching 
(63). Photobleaching was one of the artifacts that appeared during the study. To limit the 
bleaching, we chose bright and photostable fluorophores to reduce the duration and intensity of 
the excitation, in combination with antifade mounting reagents to minimize the photobleaching 
(63). Another limitation with fluorescence dyes was spectral overlapping. Spectral overlap can 
occur when two fluorophores are within the same spectrum of excitation and emission, which 
leads to overlap. It was crucial to avoid spectral overlap of fluorophores when multiple 
fluorophores were in use in the study. This can be a consequence when imaging using a 
fluorescence microscope where the researcher does not know which fluorophore was emitted 
and cross-linking of the dyes may appear. To avoid the problem, we looked for spectral overlap 
in reference to the manufacturer’s spectrum viewer (63).  
4.1.3 The mixed technique is optimal for multiple labeling  
As already mentioned in the result, optimization of multiple labeling techniques was a part of 
this project. Antibodies combination using multiple labeling techniques was exceedingly 
difficult and sensitive to optimize compared to direct fluorescence labeling. The difficulty of 
multiple labeling technique optimizations is cross-reactivity between different antibodies. To 
avoid this, the researcher must be aware of which antibodies are utilized, the animal the 
antibody is raised in, and which fluorophores are conjugated to the secondary antibody. 
Additionally, avoid using antibodies that are raised in the same species to avoid cross-reactions 
and thereby non-specific binding of antibodies. With this in consideration, we were able to 
combine laeverin and CK-7 antibodies and label both FFPE and cryo-sections using multiple 
labeling techniques. We were able to experiment with two different techniques, where the 
sandwich technique and the mixed technique showed similar results. Both the sandwich 
technique and the mixed technique showed sufficient contrast and signal detection using the 
DV microscope with a 60X/NA 1.42 oil-immersion objective lens (Figure 19). Thus, we 
choose to continue with the mixed technique due to this technique was optimal and time-
efficient compared to the sandwich technique. 
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4.1.4 Challenges of imaging FFPE placenta sections on the OMX (SIM) 
OMX is an extremely sensitive microscope, thus it was necessary to obtain a high-quality 
labeled sample for generating high-resolution and super-resolution images with the OMX. 
Sample preparation-steps for both FFPE and cryo-sections were crucial and necessary to be 
optimized. However, challenges did occur while imaging FFPE sections on the OMX. The main 
challenge was the natural autofluorescence in the placenta sections which made it difficult to 
distinguish the signals from the fluorescence markers used in this study. The autofluorescence 
signal interfered with the imaging and resulted in creating artifacts from the reconstruction in 
SIM in the form of haloing effect, which limited the capabilities of the instrument to properly 
reconstruct the image, and not allowing for clear observation of cellular structures within the 
tissue.  
There are various methods for diminishing autofluorescence in FFPE samples, ranging from 
exposure to light to a variety of chemical treatments (70, 98-100). One of the methods chosen 
for this study was to incubate the slides in a 150 mM glycine solution after the deparaffinization 
step. As mentioned in the Methods section, the solution was used to neutralize free aldehydes 
that might lead to cross-binding of the markers in the sample. The autofluorescence control in 
FFPE placenta sections were characterized by preparing unlabeled sections which were imaged 
by DV microscope. We set all the channels to 50% excitation intensity and 50 acquisition 
time to observe the response of autofluorescence through the four channels (Figure 15). Natural 
autofluorescence signals from fetal- and maternal red blood cells were observed in the FFPE 
section but not in the cryo-section (Figure 17).  
To our knowledge, there have been published studies focusing on reducing autofluorescence 
background (70, 77, 98). The study by Viegas et al. reported that pre-treating the FFPE tissue 
with short duration, high-intensity UV irradiation and Sudan Black B (SBB) reduced the 
autofluorescent background (77). Thus, this application could be tested in placenta samples to 
diminish autofluorescence. Due to time limitations, we were not able to investigate this 
hypothesis. However, it could be implied in future studies. 
Another challenge that occurred with imaging FFPE sections (and cryo-sections) generated by 
OMX was oil matching. This is a standard challenge occurring during OMX imaging which is 
still thoroughly investigated by the Optical Nanoscopy Research Group at UiT. Oil mismatch 
can be monitored by observing the point spread function (PSF) in the orthogonal view of the 
OMX software (S4 in Supplementary). Observing asymmetrical PSF in the orthogonal view 
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indicated oil mismatch. This artifact could be optimized by adjusting the refractive index of the 
immersion oil. Changing the oil will lead to refractive index enhancement of the PSF 
(symmetrical shape can be observed) and thus reduction of the artifact. However, oil match for 
multi-color samples is challenging. Due to oil matching corresponding to one specific 
excitation wavelength, it leads to haloing or doubling artifacts because of suboptimal oil 
matching for different excitation wavelengths. Therefore, the best solution to minimize the 
artifacts was to match the oil with the excitation wavelength (channel) of interest.  
4.1.5 Super-resolution obtained using cryo-sections instead of FFPE 
sections  
DV microscope was used to generate high-resolution deconvolved images with a 60X/NA 1.42 
oil immersion objective lens. For further investigation of the region of interest (ROI) of the 
tissue, the same parameters were used to generate super-resolution with OMX using SIM 
reconstruction. Acquiring high-resolution images was challenging and needed optimization. It 
also depended on the different markers and types of sections used for this study. Regardless of 
using the same labeling markers, the results from FFPE-section and cryo-section were 
significantly different. Contrast enhancement and the reduced out-of-focus signal were 
generated from the cryo-section (Figure 22B). Hence signal detection from the FFPE section 
showed poor contrast and signal which made it difficult to observe morphological structures 
(Figure 22A). A complementary study was performed in this master project to optimize the 
FFPE section imaging with OMX (not presented in the thesis). However, due to the artifact 
challenges mentioned above, we excluded super-resolution studies with FFPE sections, thus 
cryo-sections were used for super-resolution investigation of ROIs in the sample from normal 
and PE placentas.  
The cryo-sections were prepared following the Tokuyasu method, developed by Kiyoteru 
Tokuyasu in the 1970s for preparing fixed cryo-sections and cryo-protected biological 
specimens for electron microscopy (93). The microscopy results following the Tokuyasu 
method for human placenta cryo-sections have been shown to work sufficiently from previous 
studies (94). The technique included sucrose infiltration which was performed on placenta 
specimens during tissue preparation to prevent tissue collapse and avoid crystallization during 
freezing of the biological material. Placenta tissues are a complex structure of chorionic villi 
submerged in the maternal blood. To maintain the structure, the sucrose immersion step was a 
crucial step for tissue preservation. The protocol designed by Bernhard and Virion early in the 
70s has been modified since then and optimized for this thesis (101).  
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Furthermore, the optimization of dissolving the cryoprotectant mixture of sucrose-
methylcellulose from the sample before labeling was also optimized. Previous super-resolution 
studies on Tokuyasu sections used cold washing of the cryo-protectant (94). However, we 
experienced unspecific and/or poor labeling on the cryo-sections using this approach. We found 
that prolonged incubation of the sample (1 hour) at 40°C was effective to remove the 
cryoprotectant and achieve optimal labeling of the placental cryosections. Therefore, we 
implemented warm wash with PBS at 40°C on a heating plate, which gave better results with 
reduced artifacts and background signals (Figure 24). In addition to performing the warm-wash 
method, we labeled the cryo-sections of 100 nm thickness instead of 400 nm thick cryo-sections 
to omit artifacts. This application (warm-wash and 100 nm thickness of cryo-sections) to our 
protocol enabled ultrastructural investigations. Significantly reduced background signals and 
artifacts including structure enhancement were observed in the SIM images obtained from 
normal and PE cryo-sections of 100 nm thickness. 
The out-of-focus light contribution, the refractive index mismatch and the autofluorescence 
appearing while imaging with the FFPE section posed an enormous challenge on the 
reconstructive algorithm of SIM microscopy. Thus cryo-sections were preferred and suitable 
for SIM reconstruction which allowed for greater ultrastructural preservation. As mentioned, 
the cryo-section with 100 nm thickness increases the axial resolution of the microscope image. 
The thin section thickness provides optical sectioning beyond the axial resolution of the 
objective lens. Thereby, super-resolution generated using SIM on 100 nm thick cryo-sections 
is more preferable. Regardless of obtaining super-resolution on 100 nm thick samples, it was 
difficult to find regions to image. Cryo-sections with 100 nm thickness were indeed fragile 
because of the thin section and were more susceptible to sectioning artifacts such as folds, 
wrinkles and tearing, as compared to the 400 nm thick cryo-sections. Therefore, limited regions 
were available to image. This limitation will hence affect histopathology studies due to these 
studies involves examining tissues in large FOV to pinpoint abnormal observations. 
Consequently, imaging cryo-sections can lead to overlook or miss abnormal regions within the 
tissue which would not be valuable for diagnostic analysis. However, an advantage with cryo-
section is that the simple sample preparation protocol is time-efficient compared to the FFPE 
section protocol.  
To sum up, the major advantage of using FFPE tissue sections over cryo-sections was the 
observation of the morphological structures and preservation in a large FOV. The comparison 
study of acquiring large FOV of FFPE and cryo-sections indicated that FFPE sections were 
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preferable for histological investigations. This study also revealed that FFPE sections were not 
adequate for the investigation of ultrastructural changes in the tissue. Nevertheless, the frozen 
sections (cryo-sections) might be beneficial of examine tissues in small regions which cannot 
be visualized in a large FOV image.  
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4.2 Microscope observations of term placentas  
4.2.1 Actin spots – a sign of fibrin clots? 
The present morphology study of the human placenta from normal and PE pregnancies using 
phalloidin-Atto 647 N dye revealed an interesting observation of actin spots in the FFPE tissue 
sections. We found that the actin spots were abundantly localized in the chorionic villi in both 
normal and PE placentas (Figure 21). It is evident from the results and previous findings that 
placental actin filaments are present in the chorionic villi including the syncytium microvilli 
brushborder, endothelial cells, and pericytes (102). It could be argued that the actin spots may 
have been an artifact representing some sort of unspecific binding during tissue preparation and 
labeling, thus not staining actin filaments. This observation merits further study.  
The limited number of publications regarding actin filaments in human placenta tissue made it 
difficult to understand our findings of the specific actin spots. However, it could be 
hypothesized that our observation of actin spots might be associated with placental fibrosis. 
Previous studies have documented that fibrin deposition is morphologically important in 
contrast to earlier discoveries that fibrin marks pathological process and placental aging, 
including observing fibrin deposition in the healthy and pathological placentas at all stages of 
pregnancies (103). Placental fibrosis is present through the pregnancy and a large amount was 
recognized at the term placenta (103). It is known that fibrosis is a common pathologic process 
that takes place in tissue inflammation or injury (104). Disease-related injuries and 
inflammations in organs might trigger a cascade effect of cellular responses that result in the 
accumulation of tissue fibrosis (104-106). This is identified in the connective tissues as 
overproduction of the extracellular matrix (ECM). Furthermore, studies have confirmed that 
fibrosis has a significant key role in the maintenance of ECM and regulation of injury and 
inflammation in the connective tissues (106).  
The mechanism of fibrosis in the PE chorionic villi remains unclear, but studies have suggested 
that placental ischemia and hypoxia might be involved (107, 108). Another study confirmed 
that overexpression and deposition of collagen I were found in the ECM (106). A newly 
published study by Feng et al. have analyzed the fibrin deposition and expression of collagen I 
in the human placenta, in immortalized first-trimester placental trophoblast cells and mice 
models (109). They demonstrated that collagen I induce preeclampsia-like symptoms by 
repressing the invasion of trophoblasts.  
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Several studies have demonstrated that the majority of ECM in mammalian cells are collagen 
and involved in the maintenance of tissue structures, development and ECM-remodeling (106, 
109-111). Furthermore, studies have speculated that fibrosis might be an important pathological 
event in the PE placenta depending on the excess of collagen I deposition (110, 112, 113). This 
led to the finding of overproduction of collagen 1 in form of fibrosis in PE stem villi and 
terminal villi compared to the normal placentas (109, 114-116). In our study, we were not able 
to find any significant difference (p-value > 0.05) in the number of actin spots present in PE 
placentas compared to healthy placentas. However, it can be assumed that our quantitative 
analysis was not accurate due to the low quality of the method. Thus, a thorough quantification 
needs to be performed to verify the observations. 
Additionally, another study reported that actin filaments were released into the ECM from the 
cells while dying (115). Thus, it could be argued that the reason for the detection of actin 
filaments using an actin-specific marker (phalloidin-Atto 647 N) in different subtypes of the 
chorionic villi might be linked to the fact that deposition of actin in ECM is related to the 
fibrosis in chorionic villi. However, a thorough investigation is needed following quantitative 
analysis on multiple placenta samples from normal and PE with z-stack serial sectioning to be 
sure of specific localization of the actin spots. Additionally, a preliminary study on collagen I 
marker could be also performed to control the actin spots observations.  
4.2.2 Quantification of syncytial knots  
In 1893 the German pathologist Georg Schmorl reported the presence of multinucleated 
syncytial fragments trapped in the lungs of women with eclampsia who died during pregnancy 
(32, 117). The multinucleated syncytiotrophoblast is identified as syncytial fragments or 
syncytial knots and differs in size and shape (32, 118). The nuclei are present arbitrarily in the 
surface of hSTB and the cytoplasm in early pregnancy. However, at term regions of 
syncytiotrophoblast with nuclei become aged and apoptotic leading to extrude and aggregate 
as membrane-enclosed multinucleated structures (119). Studies have revealed that deportation 
of SK was found in the maternal circulation, thus trapped in the arterioles and capillaries of the 
maternal lungs causing severe complications (21, 32, 119, 120). Numerous studies have found 
an increased number of SK in term placenta that is associated with pregnancy-related disorders 
cases, such as IUGR and PE (119). Yet the cause of the shed and deposition of SK from the 
placenta is largely unknown. 
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In the current study, we were able to identify SK in full-term healthy placentas and preeclamptic 
placentas (Figure 20). Additionally, we found that there were significant differences (p-value 
> 0.05) in the number of syncytial knots in PE and normal. Thus the research indicates that an 
increased number of syncytial knots were present in full-term PE placentas compared to normal 
placentas (Table 5), which supports the previous findings (32, 121-124). To date, the function 
of SK and the mechanisms of the formation and transportation, including the increased number 
of syncytial knots in PE are still unclear. Nevertheless, a study by Tenney and Parker 
hypothesized that syncytial knots in PE may reflect on hSTB aging or apoptotic death due to 
the inactivation of transcription and replication of hSTB which may have led to several 
molecular apoptotic signaling pathways activation (120, 125). Moreover, another study 
hypothesized that SK formation is linked to decreased and inactivity of anti-apoptotic proteins 
(125). Thus they quantified the density of SK in chorionic villi and identified an increased 
amount in PE which might be a result of hypoxia, hyperoxia or oxidative stress (125). 
Additionally, it can be assumed that the significant increase in the formation of SK in the PE 
placenta might indicate the changes in hormonal factors, leading to cause changes in blood flow 
(126).  
Although, it can be argued that in this study the quantitative measurement was not accurate due 
to the measurement being done by using naked eyes. In addition, only a single large FOV image 
of each sample (normal (n=5) and PE (n=5)) was used to estimate the number of SK. Hence 
limits the quantitative analysis of SK within the tissues to only measuring one region of the 
whole tissue section. However, the optimization and enhancement of quantitative 
measurements need to be addressed in future work. Another limitation is the number of 
placentas used for this study. The limited amount of available placenta tissue might decrease 
the quality and quantity analysis for this study. Thus, it would be preferable to enhance the 
study by including more placentas from the PE and normal pregnancies to obtain more precise 
information. Lastly, the observation of SK in the large FOV images could simply be artifacts 
caused by tangential sectioning (Figure 5B). Therefore, it would be wise and beneficial to 
acquire z-stack serial sectioning and perform labeling on the z-stack serial sections to ensure 
the abnormal structures. Z-stack serial sectioning allows for a z-section visualization of the 
tissue, thus enhance the observation and pinpoint the abnormal features and lesions in the 
placenta tissue. 
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4.2.3 Disorganized brushborder in PE? 
The preliminary study of normal and PE cryo-sections fluorescent-labeled with CMO and DAPI 
showed features of syncytiotrophoblast microvilli at the apical surface (Figure 24), thus we 
were able to pinpoint the localization of microvilli in normal and PE chorionic villi due to super-
resolution of the chorionic villi acquired from the SIM reconstruction. The PE syncytial 
microvilli seem to look disorganized compared to healthy tissue, however difficult to predict 
our observation. A review article by Redman et al. have reported the microscopy finding of 
microvilli clothing the apical surface in the normal term, whereas PE syncytium microvilli were 
observed to be distorted and shed as placental debris (127). The microscope observation from 
the study did not look similar to our observation. It could be argued that tangential sectioning 
differences of the healthy and PE samples may have given a false-positive or false-negative 
observation of the microvilli. 
Another argument for not observing the same observation as Redman et al. could be the 
different preparation methods applied. In this study, the frozen tissues were rinsed with sodium 
chloride to remove the maternal blood and then fixed in PHEM buffer to preserve the structures. 
This method may have led to removing all the shed materials at the apical surface of the 
chorionic villi, thus could be the reason for not observe the same distorted microvilli and 
placental debris shedding as Redman’s ultrastructural electron microscope observations. An 
application for future study could involve using another tissue preparation (fixation) method 
that excludes the removal of maternal blood and placental debris.  
Although, it is known that placental debris is shed from microvilli and out in the maternal 
circulation (127). The placental debris ranges from multinucleated deported 
syncytiotrophoblast (20-100 µm) to sub-cellular fragments (10-60 nm) and have different 
biological functions, cargo and modes of production that may contribute to normal placentation 
(127). Hence, oxidative and inflammatory stress occurring in PE might activate hSTB to 
produce more and larger microvesicles that have pro-inflammatory, anti-angiogenic, and 
procoagulant activity (127). Thus could be hypothesized the reason for observing microvilli 
disorganized in PE tissue compared to normal tissue. 
Nonetheless, Redman et al. were able to generate ultrastructure of the normal and PE syncytial 
surface using an electron microscope. We can confirm from this investigation that we were also 
able to generate super-resolution images using an OMX microscope, thus observe structural 
details of the microvilli in both normal and PE chorionic villi. Hence the distorted microvilli 
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and placental debris observations were limited which may have resulted from the biological 
implication as mentioned earlier and not from the instrument. Using SIM was beneficial for this 
study due to the reconstruction improved the resolving of structures beyond the diffraction-
limited resolution of a conventional optical light microscope, such as confocal microscopy and 
deconvolution microscopy. Additionally, this method allowed for 2X spatial resolution 
compared to the conventional fluorescence microscopes (84, 128). Although electron 
microscope is capable of greater resolution studying at a molecular and atomic level, SIM is 
easier, faster and more conventionally available to use as to the sample preparation is similar 
as for the optical fluorescence microscopes (94, 129). Whereas EM sample procedures are long 
and complicated.  
Nevertheless, in-depth investigation is needed with more placenta samples and optimization of 
the preparation method. Additionally, for future studies it would be favorable to explore PLAP 
and phalloidin-Atto-647 N markers together to observe the microvilli disorganization in PE 
tissue due to the PLAP marker is STBM specific and phalloidin-Atto 647N to stain the actin 
filaments composed in the microvilli. This might give a better understanding of the 
disorganized brushborder of syncytial microvesicles and placental debris in spatial resolution. 
Due to time limitations in this project, we were not able to investigate with this approach, but 
could address to the future preliminary studies.  
4.2.4 PLAP - a potential biomarker for syncytial microvesicles  
As mentioned, the syncytial layer of the chorionic villi sheds placental debris into the maternal 
blood including subcellular fragments, syncytial knots, apoptotic bodies, microvesicles, 
nanovesicles and exosomes (127). The placental debris carries placenta-specific molecules, 
proteins, immune molecules, organelles, DNA fragments and RNA fragments that may 
contribute to the regulation of normal placenta physiology (117, 127, 130). Hence studies of 
their functional properties are still not clear. It seems evident that syncytiotrophoblast 
microvesicles (STBM) contribute to maternal-fetal intercellular communication and 
inflammatory responses including activation of monocytes, granulocytes, and endothelium 
(127).  
Other studies found an increased amount of circulating microvesicles in the plasma of PE 
pregnant women compared to normal pregnant women (52, 74). Redman and Sargent 
determined that oxidative stress might alter the placental physiology to cause the shedding of 
microvesicles into the maternal circulation (131). STBM carries a wide variety of pro-
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inflammatory molecules, including cytokines and chemokines and others (127). Hence their 
function in pathophysiology and the release of STBM related to complications of pregnancy is 
still in a formative stage. The immunofluorescence analysis in this study showed expression of 
the PLAP at the apical surface of the syncytial plasma membrane in healthy placenta (Figure 
25). However, with the super-resolution image, we were able to observe signal detection from 
the PLAP marker at the brushborder (apical surface) of hSTB. Thus, we could predict that the 
PLAP marker did work and was highly expressed at the apical surface of the healthy syncytium. 
Nevertheless, it was difficult to visualize the morphology of the microvesicles due to the size 
and structural diminution of the microscopy result. To observe the structures of microvesicles, 
further optimization is needed in addition to a thorough quantitative and morphological 
comparison of microvesicles in healthy placentas and placentas from women with 
preeclampsia,  
A study reported quantitative analysis on placental-derived exosomes by determining the ratio 
of PLAP exosomes (132). The findings revealed that quantification of the number of placental-
derived microvesicles in maternal circulation were higher in early-onset and late-onset PE 
compared with normal pregnancy (132). This discovery indicated that PLAP microvesicles 
could be a promising biomarker for quantitative research of the PE predictor. Due to time 
restrictions, we were not able to investigate PLAP markers in PE placentas. Thus, we can 
explore the PLAP marker on PE placentas for future research of understanding PLAP 
expression and the localization in relation to PE pathophysiology mechanisms. Since the studies 
have addressed that placental microvesicles are secreted by hSTB and deported into the 
circulation, it could be hypothesized that the microvesicles containing cargos that might have 
important diagnostic information about PE (132). Thus for the future aspect, it would be 
interesting to isolate and perform molecular profiling of PLAP STBM for diagnostics purposes 
which might have great importance in the PE prediction in the early stage of pregnancy. The 
procedure can be studied non-invasively.  
4.2.5 Subcellular localization of laeverin in PE placenta  
Laeverin is a member of the aminopeptidase family. This family is involved in the maintenance 
of homeostasis including maintenance of normal pregnancy hypertension regulation and 
antigen presentation (47, 133-135). In a study by Sitras et al. laeverin mRNA, among other 
genes, were significantly upregulated (increased tenfold)  which led to several molecular studies 
of the involvement of laeverin in the pathophysiology of preeclampsia (95). Nystad et al. found 
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laeverin expression in the cell membrane of hCTB of term placentas from healthy women (48). 
In comparison placentas from women with preeclampsia demonstrated laeverin expression in 
the cytoplasm of trophoblast cells. It is evident from the microscope observation that plasma 
membrane expression of laeverin was shown in hSTB and hCTB, in addition to the cytoplasmic 
expression of laeverin in healthy placentas (17). Due to the expression and localization in 
normal placenta observed in the study, they were able to observe upregulation of laeverin 
protein in PE placentas thus further investigated the role of laeverin in the PE pathophysiology 
(17, 47, 48).  
Furthermore, the immunoelectron microscopy analysis demonstrated that the protein was 
expressed in the microvesicles within the cytoplasm, including in extracellular space, syncytial 
knots and the fetal capillaries in the PE placenta, and that there was a large amount of protein 
expressed in the PE placenta compared to a healthy placenta (48). However, the study was only 
based on detection of the size in the electron microscopy studies, whereas in our study with 
PLAP biomarker showed specific expression in the syncytiotrophoblast-derived microvesicles.  
In this current study, we used commercially available antibodies against laeverin and CK-7 to 
observe the expression using advanced immunofluorescence microscopy (Olympus VS120) in 
normal (n=5) and PE (n=5) placentas. It could be assumed from the microscope observation 
that co-localization of laeverin and CK-7 was detected in the healthy placentas. In PE placentas, 
we can assume that the laeverin expression was observed in the syncytial plasma membrane 
and cytoplasm of the trophoblast. Although the assumed observations support previous 
findings, it was difficult to observe the expression on the low-resolution images (Figure 26), 
therefore difficult to predict and pinpoint our observation. Further optimization of the multiple 
labeling with laeverin and CK-7 for the super-resolution method is needed. Additionally, a 
preliminary study with the application of life-cell imaging of placental villous explant could be 
more informative for observing the localization distribution of laeverin.  
However, the assumed observation of accumulation of laeverin in preeclamptic placentas might 
have resulted from that the protein was not fully processed during folding which might have 
led to misfolding, protein damage or changes in post-translational modification in PE (133, 
136). Changes in epigenetic regulation (DNA methylation, histone modification, non-coding 
RNA expression) may also play a key role in the cause of overexpression of the protein in PE 
(137, 138). Due to the protein’s involvement in cellular homeostasis, it can be hypothesized 
that dysregulation of laeverin protein might disrupt homeostasis in cells (133).  
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Furthermore, a preliminary study using only laeverin antibody, CMO and DAPI allowed for 
super-resolution and enabled the observation of overexpressed laeverin in PE fetal capillary 
(Figure 27B). Although this is a preliminary study on a single tissue, it could be hypothesized 
that laeverin may function as a scavenger in the elimination of dangerous particles and 
clearance of toxins from circulation. This could also be the reason for laeverin expression in 
the normal fetal capillary walls. On another note, overexpression of laeverin in fetal capillaries 
might have to do with placental ischemia in PE. Hence, not enough reports are associated with 
the exact molecular mechanism behind this. Thus, it would be interesting to include a 
preliminary study with a severe preeclamptic (eclamptic) placenta sample to compare the 
distribution of the protein in the different stages of the diseases and thereby might have a better 
understanding of laeverin expression and subcellular location.  
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4.3 Strengths and limitations of the study  
In this master project, the optimal preparation-steps including concentrations and incubation 
times of the biomarkers and labeling techniques for FFPE- and cryo-sections of the human 
placenta was found. Thus for future research, this methodology will be time-efficient. Due to 
the high-resolution and super-resolution microscopy method were sample-dependent, we were 
able to optimize the sample preparation for imaging as well. Additionally, the optimization of 
the methodology has minimized the use of equipment which contributes to more eco-friendly 
preliminary tests. Another advantage of the project was that the optimized technique for cryo-
section allowed for studying the subcellular localization of compartments in placentas with an 
OMX microscope. The study revealed that ultra-thin cryo-sections improved the super-
resolution ability to resolve and visualize the detailed morphology of the chorionic villi. Thus 
super-resolution images contained more detailed information compared to low-resolution 
images. Preliminary studies of biomarkers in this master project allowed for targeting 
interesting placenta-specific proteins which opened the perspective that biomarkers may have 
a potential role in the prediction and diagnosis of PE. However, a further thorough study is 
required to understand the role of the biomarkers in normal and PE placentas.  
Nevertheless, there were several limitations in this study, primarily related to the lack of a 
sufficient number of PE cases to address the common PE placental lesions and morphology 
features. Additionally, the analysis of different placenta tissues from patients was also limited 
due to the anatomy and morphology differences of the patients. This might limit the possibility 
of predicting abnormal feature visualization of the tissues and thus difficult to predict if it is PE 
characteristics or not. However, investigating more samples from different PE women and 
comparing the finding to the controls gave us a better understanding of what might be placental 
attributes.  
Secondly, the organ is dynamic, therefore it is difficult to identify the pathophysiological 
changes within a tissue section by only analyzing the section in a snapshot in time. As a 
consequence, the major limitation with histological investigations is that the placenta has an 
extremely convoluted nature and thus possible to be confused and difficult to pinpoint the 
abnormal structures using a microscope. This is because artifacts may occur from tangential 
sectioning of the microscope as mentioned earlier. For future recommendations, z-stack serial 
sectioning would provide more accurate and greater information about the tissue.  
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Furthermore, quantitative analysis of abnormal structures and placental lesions was observed 
in the microscope images. Due to a complex tissue and the fact that FFPE sections are large, it 
was difficult to perform a quantitative assay of the characterized features (actin spots and 
syncytial knots) on the whole tissue section. Large FOV images allowed us to identify the 
features on one region of the tissue. Consequently, the quantitative analysis was performed 
using naked eyes on a single large FOV for each sample. This resulted in uncertain predictions. 
Hence, adequate analysis is necessary to undoubtedly quantify the observations. A future aspect 
for enhancing quantitative studies in clinical histopathology research could be using artificial 
intelligence (AI) technology. A preliminary study could be performed on designing/training an 
AI-algorithm to characterize and quantify abnormal placenta features objectively. This aspect 
might have a significant improvement in clinical research and a diagnostic setting.  
Another limitation of this study was the use of ultrathin cryosection which might be a 
disadvantage for pathological investigations. The ultra-thin section may limit the regions of the 
sample to examine due to the sections being extremely fragile and easily damageable as 
mentioned earlier. Thus, when we imaged the sections, we were able to observe some folded 
or damaged regions of the tissue which limited the imaging area for high-resolution and super-
resolution. Consequently, this might lead to overlooking areas that may be abnormal, thus 
giving us false-positive or false-negative results.   
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5 Conclusions 
In conclusion, the optimized methodology for FFPE- and cryo-sections of placenta tissues were 
well suited for histological investigation using the advanced fluorescence microscopy method. 
The FFPE sections were more preferable for acquiring large FOV low-resolution images. 
Whereas, ultra-thin cryo-sections were better for generating super-resolution images, which 
allowed to observe detailed morphology at a subcellular level of the chorionic tissue. In this 
study, we used immunofluorescence microscopy to compare the expression of placental 
biomarkers (laeverin, PLAP and CK-7) in combination with non-specific commercially 
available fluorescent dyes (phalloidin-Atto 647 N, CMO and DAPI). By using phalloidin-Atto 
647 N marker for actin staining, we found abundant actin spots independently attached to the 
chorionic villi, and that there were no significant differences between healthy and preeclamptic 
placentas. Nevertheless, the actin spots seem to be associated with fibrosis deposition and thus 
attached to fibrin in the chorionic villi. The quantitative analysis revealed an increased amount 
of syncytial knots in PE compared to healthy tissues. Moreover, the biomarker investigation 
revealed expression localization of the placenta-specific proteins. The comparison study seems 
to show disorganized microvilli at the apical surface in PE placentas. The study also revealed 
that PLAP is STBM-specific and was expressed in the apical surface of the syncytiotrophoblast 
in healthy placentas. Additionally, laeverin seems to be expressed in the syncytial plasma 
membrane in the healthy placentas. The mixed multiple labeling technique using laeverin and 
CK-7 marker revealed co-localization in healthy placentas, whereas in PE placentas laeverin 
seems to be abundantly expressed in the syncytial plasma membrane and hTB cytoplasm. 
Lastly, the super-resolution microscope image showed laeverin expression in fetal capillary 
walls in healthy tissue, and overexpression of the protein was found in the PE fetal capillaries.  
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6 Future perspectives 
The master project has been a great groundwork for immunofluorescence studies using 
advanced microscopy methods. However, further investigation must be performed to fill the 
gaps in our understanding of the placental biomarkers (laeverin, CK-7 and PLAP) related to 
preeclampsia. Given that the production of placental-specific factors may contribute to the 
development of preeclampsia, it was an interesting approach to study these placental-specific 
biomarkers. Thus in this present study, the immunofluorescence mixed technique on the 
expression of CK-7 (identified human trophoblasts), laeverin (discriminates in PE/healthy 
placentas), and PLAP (STBM-specific), was successfully performed and allowed for intriguing 
observations.  
To date, the pathologists routinely use immunohistochemistry and sFlt/PIGF ratio along with 
other biomarkers as a predictor for PE. Therefore, this immunofluorescence pilot study of 
biomarkers may contribute to understanding the pathophysiology of preeclampsia and might be 
potential predictors for PE. However, these potential biomarkers as mentioned needs to be 
further studied in a bigger clinical material. Our ultimate goal is to find an early pregnancy test 
for the prediction of PE, thus it would be of great interest for future research to use these 
biomarkers for investigation of their potential to predict pregnancy-related diseases, as 
preeclampsia in maternal blood. Additionally, it can be achievable to perform a non-invasive 
test of PLAP or trophoblast fragments/cells in the maternal circulation in week 20 of gestation 
or first-trimester, thus predict the disorder at an early stage, closely monitor the pregnancy and 
give prophylactic medication.  
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Supplementary information  
Table S1: List of equipment, reagents and solutions  
Name Manufacturer  Cat. No. Purpose  
Sodium chloride (NaCl) 9 mg/mL Fresenius Kabi AG 896968 Rinse the collected fresh tissue  
EGTA1 Sigma-Aldrich  E4378-1006 Used to make 1X PHEM4 buffer  
HEPES2 VWR Chemicals 441476L Used to make 1X PHEM4 buffer 
PIPES3 Sigma-Aldrich P6757-500G Used to make 1X PHEM4 buffer 
Magnesium sulfate  Sigma- Aldrich  M7506-500G Used to make 1X PHEM4 buffer 
5M sodium hydroxide Sigma-Aldrich  30620-1KG-R Used to make 1X PHEM4 buffer 
FA5 Sigma-Aldrich  158127-500G Prepare 16% PFA6 
FA (16%) 
- 16 g FA5 in 100 mL MilliQ water 
-  -  To further dilute to 8% FA5 
FA5 (8%) 
- 7 mL 16% FA5 in 7 mL 1X PHEM4 
-  -  Used in 4% PFA6 solution  
PFA6 solution (4%) 
- 15 mL 0.2 M PBS7, 7.5 mL 8% FA5 diluted in 4X PHEM4, 7.5 
mL MilliQ water 
-  -  Fixate tissue and preserve tissue morphology  
Gelatine (12%)  
- 12 g gelatine diluted in 100 mL MilliQ water 
Fluka Analytical  48723-599G-5 Preserving tissue morphology  
Sucrose (2.3 M) 
- 342 g sucrose diluted in 100 mL MilliQ water 
Sigma-Aldrich  16104-1KG Preventing crystallization during freezing  
Methylcellulose (2 %) 
- 2 g methyl cellulose in 100 mL MilliQ water 
Sigma-Aldrich  M6385-100G To further dilute to 1% methylcellulose  
Methyl cellulose (1%) 
- 250 µL 2% methyl cellulose in 250 mL 2.3 M sucrose  
-  -  Prevent the tissue section from drying   
PBS7 (0.2 M) 
- 10 Ml 1M PBS in 40 Ml MilliQ water 
VWR Chemicals E404-200TABS Used in fixative  
PBS7 (1 M) 
- 1 g PBS in 1L ddH2O 
VWR Chemicals E404-200TABS Washing (Maintains intracellular Ph, which prevents cells rupturing or 
shriveling up due to osmosis) 
BSA8 (1 %) 
- 0.5 g BSA in 50 Ml 1 M PBS7 
Sigma-Aldrich A8022 Used in blocking buffer  
Xylene (mixture of isomers) 1L VWR Chemicals  28975.291 Removed paraffin penetrated the tissue  
Ethanol absolute 100 Vol. % 1L VWR Chemicals  20821.296 The rehydration step reintroduces the water molecules into the tissue  
Ethanol 96 Vol. % 5L VWR Chemicals  20823.362 The rehydration step reintroduces the water molecules into the tissue  
Ethanol 70 Vol. % 
- diluted from 96 Vol. % 
-  -  Rehydration of FFPE samples  
Citric acid monohydrate  Sigma-Aldrich  C-7129 Used in Citrate buffer  
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Name Manufacturer  Cat. No. Purpose  
- Solution A: 10.5 g citric acid monohydrate in 500 Ml MilliQ 
water 
Sodium citrate 
- Solution B: 29.4 g sodium citrate in 1 L MilliQ water 
Sigma-Aldrich C-7254 Used in Citrate buffer 
Citrate buffer 
- 18 ml solution A and 82 ml solution B 
-  -  Enables rehydration and antigen retrieval by breaking cross-links 
between antigens and any substances in its fixation medium  
Glycine (bleaching solution) 
- 150 mM  11.6 g glycine + MilliQ water up to 1000 mL 
Sigma-Aldrich G7126-100G Reducing the unspecific cross-binding of the fluorescent markers and 
antibodies to the sample. 
TBST9 (washing solution) 
- 2.5 ml 20% Tween 20 + in 1L 1X TBS 
-  -  Decrease background staining and reagent spreading in procedures 
10 X TBS10 
- 61 g Trizma base + 90 g NaCl + MilliQ water up to 1000 mL 
-  -  To further dilute to 1X TBS for TBST (washing solution) 
0.5M Tris base -  -  Used in 10X TBS10 solution 
9% 1.54M Sodium chloride (NaCl) -  -  Used in 10X TBS10 solution 
Tween 20  VWR Chemicals  663684B Used in TBST (washing solution) 
Wah-N-Dry coverslip rack  Sigma-Aldrich WSDR-100 A rack for Cryo-section samples  
Cryogenic storage vials  Thermo Fisher  5000-0020  the placenta samples on pins were placed in the vials and store in the 
nitrogen tank 
Tube Rotator B7925 Agar Scientific Ltd.  -  -  
22 x 22 mm #1.5 coverslip  VWR 48393-151 Tissue sample placed on the coverslip  
British Standard Microscope slide  Thermo Fisher  -  Assemble coverglass  
Poly-L-lysine (0.2 mg/Ml) 
- 0.2 mg poly-L-lysine in 1 mL Milli-Q water 
Sigma-Aldrich P1274 Provide adherence between tissue section and cover glass  
Prolong Gold Antifade Mountant  Thermo Fisher P36934 Mounting medium  
Dental glue Picodent twinsil 22 
- 1:1 Solution A and Solution B  
-  -  Seal the edge of the mounted cover glass 
1EGTA: Ethylene glycol tetraacetic acid (ethylene glycol-bis (β-aminoethyl ether)-N, N, N’, N’-tetraacetic acid) 
2HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
3PIPES: 1,4 piperazine bis (2-ethane sulfonic acid) 
4PHEM: PIPES-HEPES-EGTA-Magnesium sulfate 
5FA: Formaldehyde  
6PFA: Paraformaldehyde  
7PBS: Phosphate buffered saline 
8BSA: Bovine serum albumin  
9TBST: Tris buffered saline with Tween 20 
10TBS – Tris buffered saline  
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Preservation  Target  Antibody  Name  Manufacturer  Cat. No Working 
concentration  
1 Normal  Cryo-section Syncytial 
microvesicles  
1’Ab3 PLAP4 (8B6) Mouse Monoclonal Antibody Santa Cruz 
Biotechnology  
Sc-47691 1:50  
2’Ab3 Goat Anti-Mouse IgG (H+L) Cross-
Adsorbed Secondary Antibody, Alexa Fluor 
Plus 488 
Thermo Fischer  A11001 1:250 
FFPE2 section  
Membrane  -  CellMask Orange  Thermo Fischer C10045 1:2000 





Laeverin  1’Ab3 Anti-Laeverin Rabbit Polyclonal Antibody Abcam Ab185345 1:100 
2’Ab3 
 
Donkey Anti-Rabbit IgG (H+L) Highly 
Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 647 




1’Ab3 Cytokeratin 7 Mouse Monoclonal Antibody Santa Cruz 
Biotechnology  
Sc-23876 1:100 
2’Ab3 Goat Anti-Mouse IgG (H+L) Cross-
Adsorbed Secondary Antibody, Alexa Fluor 
Plus 488 
Thermo Fischer A11001 1:250 
Nuclei  -  DAPI5 Thermo Fischer 62247 1:1000 
3 Normal  FFPE2 section Trophoblast 
cytoplasm 
1’Ab3 Cytokeratin 7 Mouse Monoclonal Antibody Santa Cruz 
Biotechnology 
Sc-23876 1:100 
2’Ab3 Goat Anti-Mouse IgG (H+L) Cross-
Adsorbed Secondary Antibody, Alexa Fluor 
Plus 488 
Thermo Fischer A11001 1:250 
PE1 
Membrane -  CellMask Orange  Thermo Fischer C10045 1:2000 
Nuclei  -  DAPI5 Thermo Fischer 62247 1:1000 
4 Normal  FFPE2 section  Actin  -  Phalloidin-Atto 647 N Sigma-Aldrich  65906 1:100 
PE1 
Membrane  -  CellMask Orange  Thermo Fischer C10045 1:2000 
Nuclei  -  DAPI5 Thermo Fischer 62247 1:1000 
5 Normal  Cryo-section  Trophoblast 
cytoplasm 
1’Ab3 Cytokeratin 7 Mouse Monoclonal Antibody Santa Cruz 
Biotechnology 
Sc-23876 1:100 
2’Ab3 Goat Anti-Mouse IgG (H+L) Cross-
Adsorbed Secondary Antibody, Alexa Fluor 
Plus 488 
Thermo Fischer A11001 1:250 
Actin  -  Phalloidin-Atto 647 N Sigma-Aldrich  65906 1:100 







Preservation  Target  Antibody  Name  Manufacturer  Cat. No Working 
concentration  
6 Normal  
 
Cryo-section  Membrane  -  CellMask Orange  Thermo Fischer C10045 1:2000 
PE1 
Nuclei  -  DAPI5 Thermo Fischer 62247 1:1000 
7 Normal  
 
Cryo-section  Laeverin 1’Ab3 Anti-Laeverin Rabbit Polyclonal Antibody Abcam ab185345 1:100 
PE1 2’Ab3 Donkey Anti-Rabbit IgG (H+L) Highly 
Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 647 
Thermo Fischer A31573 1:500 
Membrane  -  CellMask Orange Thermo Fischer C10045 1:2000 
Nuclei   -  DAPI5  Thermo Fischer 62247 1:1000 
1PE: Preeclampsia 
2FFPE: Formalin-fixed paraffin-embedded  
3Ab: Antibody  
4PLAP: Placental alkaline phosphatase  






S3: Microscope image representation of poor deparaffinization and 
rehydration technique 
 
S3: Microscope image representation of poor deparaffinization and rehydration technique. 4µm thick FFPE 
healthy placenta section labeled with phalloidin-Atto 647 N for F-actin staining (displayed in green), membrane 
stained with CellMask Orange (displayed in red), nuclei counterstained with DAPI (displayed in blue). (A) Large 
FOV generated using DV microscope with 20X magnification. (B) Enlarged image from (A). Reduced signal, 
blurry and unclear regions are observed due to poor deparaffinization and rehydration technique of some regions 




S4: Orthogonal view of the point spread function 
 
S4: Orthogonal view of point spread function. The point spread function is viewed on an orthogonal view. In this 
case, the PSF is symmetrical which indicated an optimal refractive index match between the immersion medium 
and the microscope objective.   
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S5: A general protocol for fluorescent immunolabeling on FFPE tissue 
sections 
Samples: 
Semithin sections (4µm-5µm) of Formalin-Fixed Paraffin-Embedded (FFPE) tissue.  
Mounting substrate #1.5 coverslips (VWR cat# 48393-151 or equivalent) coated with 
Poly-L-Lysine (Sigma, cat# P1274) 
 
Handling tips: 
When working on samples laying directly on coverslips, it is convenient to place them in 
a coverslip rack, staining jar or similar, during the deparaffinization steps, and 
manipulate them with wide tip tweezers.  
 
  
Reagents (fill in the information according to the experiment plan) 
 
Available excitation wavelengths for fluorescence imaging on the DV/OMX: 
642nm / 568nm / 488nm / 405nm 
 
Washing buffer TBST: 1X TBS + 0.05% Tween 20 (pH 8.4)  
• 2.5 ml 20% Tween 20 + in 1L 1X TBS 
  
Preparation of 10X TBS (0.5M Tris base, 9% 1.54M NaCl-pH8.4) 
• 61 g Trizma base + 90 g NaCl + Milli-Q water up to 1000 mL 
• Adjust pH to 8.4 using concentrated HCl  
 
Blocking / Dilution buffer: 1% BSA in TBST (1 g BSA in 100 ml TBST). 
 
Citrate buffer (pH 5.98): 
- Solution A: 10.5 g citric acid monohydrate in 500 ml Milli-Q water 
- Solution B: 29.4 sodium citrate in 1L Milli-Q water 
- 18 ml solution A and 82 ml solution B, make up to 1L with Milli-Q water 
 
Bleaching solution:  
- 150 mM Glycine solution (SIGMA-ALDRICH cat# G7126-100G)  
Procedure: 




1. Deparaffinization and rehydration (change all the solutions every 2 weeks, fill up in 
between). After sectioning, leave the sections in 60°C overnight, then proceed with the 
following steps: 
- 3 x 5 min: Xylene  
- 2 x 10 min: 100 % Ethanol  
- 2 x 10 min: 96% Ethanol 
- 1 x 10 min: 70% Ethanol 
- 1 x 30 min Bleaching solution 
- 1 x 5 min: MilliQ water 
 
2. Antigen retrieval, 10 min microwaving in citrate buffer (pH 5.98)  
- Pre-warm buffer to around 95°C, and place sections in a beaker filled with hot buffer. 
- Microwave 2 x 5 min @50% power. Fill up with a hot buffer in between if the level gets 
low.  
- Let cool down sections in the buffer for 20 min at RT. 
 
3. Washing and blocking steps 
- wash sections 3 x 2 min with Milli-Q water and aspirate excess liquid from slides. 
- wash in TBST for 2 min 
- incubate in blocking buffer for 30 min at RT. 
  
4. Labeling with primary antibodies  
- Spin down all antibodies and dilute them in blocking buffer according to the 
recommended concentration. Makeup to 100 - 150 µl / coverslip, depending on the size 
of the tissue section. 
- Place the slides in a wet chamber (e.g., petri dish with a moisturized paper or equivalent) 
and incubate the antibodies on slides according to the recommended incubation time. 
Best results obtained with an overnight incubation at 4°C. 
 
5. Labeling with secondary antibodies 
- All steps from now on will be done under the aluminum foil, to prevent photobleaching. 
- Dilute secondary antibodies in blocking buffer according to the recommended 
concentration and incubate on slides for 1h at RT. 
- Wash 3 x 5 min in TBST 
- Wash 2 x 5 min in PBS 
 
6. Actin membrane staining (direct labeling) 
- Dilute CellMask Orange in PBS (1:2000) and incubate on slides for 15min.  
- Wash 2 x 5 min in PBS 
 
7. Cell membrane staining (direct labeling) 
- Dilute Cell Mask Orange in PBS (1:2000) and incubate on slides for 15min.  
- Wash 2 x 5 min in PBS 
 
8. Nuclear staining (direct labeling) and mounting. 
- Add DAPI in PBS (1:1000) and incubate at RT for 15 min. 
- Wash 2 x 5min in Milli-Q water 
- Aspirate excess liquid from sections, but not let them dry. 
- Apply mounting medium Prolong Gold in the center of the glass slide (see image below), 
and place the sample facing the mounting medium. Remove excess mounting medium by 
tapping gently on top of the slide with absorbent paper. Remove visible air bubbles from 
the sample by tapping gently with a plastic tweezer.  
- Seal with nail polish 
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S6: A general protocol for labeling of Placenta Cryosections  
 
1. Place the coverslips with the sections on a parafilm-covered metal plate on a heating plate. 
 
2. Warm wash 3 x 20 minutes with PBS on the heating plate (40oC).  
 
3. Indirect immunofluorescence staining:  
- Incubate 30 min with blocking buffer  
- Wash 2 x 5 min with PBS  
- Incubate 1 hour with primary antibody at RT 
- Wash 2 x 5 min with PBS 
- Incubate 1 hour with secondary antibody at RT 
- Wash 2 x 5 min with PBS 
 
4. Actin staining (direct labeling):  
- Incubate 10 min with Phalloidin-Atto 647N 
- Wash 2 x 5 min with PBS 
 
5. Membrane staining (direct labeling):  
- Incubate 10 min with CMO  
- Wash 2 x 5 min with PBS 
 
6. Nucleic staining (direct labeling):  
- Incubate 10 min DAPI  
- Wash 3 x 5 min with MilliQ-water 
- Mount with Prolong Gold, seal with dental glue and cold storage (4oC)  
 
 
S7: Coating of coverslips with Poly-L-lysine  
1. Sterile #1.5 coverslips are washed with 70% ethanol, rinsed with ddH2O, and air-dried on 
a coverslip rack.  
2. The dry coverslips are coated with 50 µL 0.2 mg/mL Poly-L-Lysine to improve the 
adherence of the cell sample to the coverslip and preventing it from detaching during 
labeling and washing.  
3. The Poly-L-lysine coated coverslips are transferred to dust-free dishes and stored at room 
temperature until use.  
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